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ABSTRACT
Bomjan, Rajdeep Ph.D., Purdue University, May 2018. YshB is a Positive Regulator
for Salmonella Intracellular Survival and Facilitates the Spatio-Temporal Regulation
of Bacterial Pathogenesis. Major Professor: Daoguo Zhou.
Salmonella pathogenesis primarily involves invasion of host cells followed by modulation of the intracellular environment for survival and replication. While tremendous progress has been made toward understanding the pathogenesis, the picture is
far from complete. In an eﬀort to characterize the role of small RNAs (sRNAs) in
Salmonella pathogenesis, we identiﬁed a previously undeﬁned small protein YshB as
a positive regulator for intracellular bacterial survival and virulence. Essentially, we
were able to show YshB was important for survival within macrophages and contributed signiﬁcantly in mouse virulence. Further, when induced within the bacteria,
YshB would lower the invasion eﬃciency. Notably, yshB expression was found to upregulate when the bacteria were inside macrophage cells. Moreover, we demonstrate
that YshB mediates upregulation of PhoP, a key modulator of Salmonella virulence.
We therefore propose a scenario where the induction of YshB mimics the intracellular
phase and therefore triggers a down-regulation of the invasion machinery.
Interestingly, during the process of elucidating the mechanism of regulation mediated by this small protein, we came across a link between bacterial pathogenesis
and fatty acid oxidation pathway. In particular, we found that FadB, an enzyme
involved in breakdown of long chain fatty acids was upregulated in the Salmonella
cells with induced YshB. FadB was previously implicated to be one of the in vivo
induced (ivi) genes, which lead us to speculate that this gene might be important to

xxi
maintain intracellular survival of Salmonella. We were able to demonstrate that the
fadB knockout mutants were indeed compromised in their intracellular life cycle.
The upregulation of PhoP and FadB in the YshB induced cells might therefore
trigger the spatio-temporal switch from invasion-competent phase of infection to a
survival-competent phase.
Based on the results we gathered, we therefore postulate a role for this small
protein as a molecular liaison to mediate a cross-talk between the invasion competent
extracellular and the survival competent intracellular phase of Salmonella.
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1. INTRODUCTION
1.1

Salmonella enterica and the Global Burden
Salmonella enterica is a Gram negative, facultatively intracellular bacterium con-

sisting of as many as 2,600 serovars belonging to six subspecies [1]. Almost all human
pathogens belong to subspecies enterica (Subspecies I), whereas the other ﬁve are
mainly found to infect cold blooded animals [2]. Moreover, some serovars cause infection among a broad-range of hosts, including humans, animals and even plants [3].
Salmonella enterica serovar Typhi however has restricted host selectivity as it can
only infect humans [4]. This unique serovar causes enteric fever (typhoid) in the human host, which is a systemic illness characterized by fever along with enlargement
of spleen and liver [5] causing signiﬁcant morbidity, mortality and global burden
worldwide, particularly in the developing world [6, 7]. In contrast, the non-typhoidal
Salmonella (NTS) strains, primarily belonging to serovars Typhimurium and Enteritidis typically cause self-limiting inﬂammatory diarrhea or enterocolitis in the
host [8, 9]. However, immunocompromised individuals are particularly vulnerable to
the systemic form of this disease [10,11]. According to an estimate, there are approximately 90 million cases of non-typhoidal Salmonellosis every year worldwide with
1 million cases in the United States [12]. Importantly, this is the leading cause of
hospitalization and death among cases arising from all food-borne illnesses with a
mortality rate of upto 0.2% [13, 14]. Consequently, to reduce and manage this global
burden, development of eﬃcient therapeutic strategies against this illness is crucial,
chieﬂy because of lack of eﬀective vaccines [15, 16] and also due to ever-increasing
incidence of multidrug resistance [17, 18].
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1.2

Pathogenesis Model
Since Salmonella enterica serovar Typhimurium (S. Typhimurium henceforth) is

an enteric pathogen, its host is infected upon ingestion of food or drinking water
contaminated with fecal or urinary particles from carriers [19]. This is followed by the
invasion of intestinal epithelium, subsequently leading to dissemination into deeper
tissues [20].
After ingestion, the immediate adverse environment Salmonella encounters is the
acidic pH of stomach. This results in the activation of several inducible genes which
constitutes for the acid tolerance response (ATR). This protects the bacteria from
the acid stress by maintaining the intracellular pH at higher values [21, 22].
In Salmonella, as in other pathogenic ﬂagellated bacteria, motility is key for virulence [23]. An unimpaired motility along with an intact chemotactic ability is necessary for eﬃcient colonization of the intestinal epithelia [24]. Interestingly, motility
is essential only during the early phases and is dispensable once the infection is established. Hence, upon contact with the host cells, motility is switched oﬀ in favor
of activation of the invasion machinery [25].
Once they reach the small intestine, they cross the mucus layer and adhere to
the intestinal epithelial cells. The attachment to host cell is facilitated by specialized
adhesive structures called adhesins that protrude from the cell surface [26]. The most
common ones are the ﬁmbrial adhesins encoded by multiple diﬀerent operons such
as lpf, pef, ﬁm and agf [27]. Moreover, SiiE, a giant non-ﬁmbrial adhesin (at 595
KDa also is the largest protein encoded by Salmonella genome) mediates the initial
contact of the bacteria to the polarized epithelial cells of host, thus facilitating the
eventual entry [28].
Following adhesion, Salmonella then preferably enters the M-cells of Peyer’s
Patches [29], although they are also seen to trigger internalization into other non-
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phagocytic enterocytes [30]. The bacteria actively mediate their internalization by
triggering a cascade of signaling events in the host cell characterized by massive actin
rearrangement [31]. Phagocytic cells are recruited as a result of this event into the
intestinal lumen followed by production of several pro-inﬂammatory cytokines, which
eventually leads to colitis [32]. The entry process also known as the macropinocytosis
results in the formation of a specialized compartment known as the Salmonella
Containing Vacuole (SCV), where the bacteria survives and eventually replicates [33].
The SCV matures as it integrates with the host endocytic pathway; however at the
later stages, it co-opts the traﬃcking to avoid fusion with lysosomes [34]. This is
also accomplished by migration towards the Golgi apparatus to facilitate acquisition
of nutrients and membrane components [35]. In few hours, the bacteria egress from
the epithelial cells and are consequently captured by the phagocytes. Majority of
them are macrophages followed by neutrophils, and are recruited by the ensuing
inﬂammatory signals [36, 37]. Also among the population of phagocytic cells are
the dendritic cells, which expedite the transport of bacterial population to the
mesenteric lymph nodes (MLN) [38]. Moreover, these specialized cells have also been
reported to directly snatch the bacteria from intestinal lumen [39]. This is followed
by systemic dissemination, where the phagocytes carry the bacteria, residing within
the SCV, into deeper tissues such as liver and spleen [40].

1.3

Salmonella enterica serovar Typhimurium Infection and Virulence
Strategies
In order to successfully establish a niche in its host, bacterial pathogens need to

adapt to new environments, which it does mainly by regulating the spatio-temporal
expression of genes responsible for virulence [41].
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1.3.1

Salmonella Pathogenicity Islands

As is common with most bacterial pathogens, the Salmonella enterica chromosome
also has large regions behaving as discrete molecular units accommodating clusters
of genes dedicated to encode a panoply of virulence factors [42, 43] known as the
Salmonella Pathogenicity Islands (SPIs) [44]. These are horizontally acquired from
unrelated bacteria during the course of evolution and typically have a low G+C
content than the rest of the chromosome [45, 46].
There are 23 such pathogenicity islands characterized so far in S. enterica, and
among these, ﬁve (SPI-1 through 5) are found in all serovars [47]. In S. Typhimurium,
the 40 kb island comprising at least 39 genes ﬂanked by the mutS and the ﬂhA
genes and located at centisome 63 of the chromosome is designated as SPI-1 [48].
This is primarily responsible for regulating the invasion machinery of this bacterium,
whereby facilitating its entry into the non-phagocytic intestinal epithelium of the
host [49]. Acquisition of SPI-1 into the genome has therefore been considered as the
most signiﬁcant event in the evolution of this bacterium towards becoming pathogenic
[50]. Whereas another island, the SPI-2 is located at centisome 31, ﬂanked by the
ydhE and the pykF genes and is responsible for intracellular survival within the host
macrophages and virulence in mice [44,51]. Therefore, these two islands contribute to
speciﬁc phases during bacterial disease progression. Owing to its complex life cycle,
the virulence in Salmonella is thus determined by multiple genes dispersed around
the chromosome [50]. In terms of their distribution, SPI-1 was found to be present
in all lineages, while SPI-2 was conspicuously absent in Salmonella bongori [45].
Furthermore, a number of genes within the SPI-1 have homologs in other
pathogenic enterobacteria [52, 53], whereas those belonging to the SPI-2 are limited
only in Salmonella [54].
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1.3.2

Virulence Plasmid

S. Typhimurium strains also harbor a plasmid called the pSLT, which is approximately 95kb in size and consists of a conserved spv locus which encodes for ﬁve
proteins [55] essential for virulence in mice. Among the proteins, SpvR is the regulator which activates the spv locus [56]. SpvA is an outer membrane protein [57],
whereas SpvB, SpvC and SpvD are eﬀectors [58] whose functions are brieﬂy outlined
in the next section.

1.3.3

Salmonella Type III Secretion Systems

Most bacterial pathogens employ a macromolecular system to secrete proteins
across its membranes into the extracellular milieu or inject directly into the cytosol
of host cells [59]. These secreted proteins, also known as the substrates mainly function in enhancing bacterial virulence by modulating a wide array of host cellular processes [60]. There are six such dedicated secretion systems in Gram negative bacteria
numbered I through VI [61]. Among these, the Type III secretion system (T3SS),
also commonly known as the “injectisome” or the “needle complex” is a nanosyringe
which eﬃciently secretes the substrates across the bacterial membranes [62]. Moreover, this system is specialized in delivering the substrates directly into the eukaryotic
cytosol, in a process called “translocation”. In such instances, the substrate proteins
are called “eﬀectors” [63]. The T3SS therefore has to traverse through three phospholipid membranes and the peptidoglycan layer of the bacteria, in order to directly
deliver the eﬀector proteins into the target host cells [64]. Characteristically, the
T3SS substrates have their secretion signal in the N-termini and are transported in
an unfolded state [60].

6
Structure-wise, the T3SS has three main subunits [60]: the “basal body” spans
both the bacterial membranes and the periplasm and also contains the cytoplasmic
components; the “needle” with a hollow core acting as a conduit protrudes externally
from the basal body; and the “tip complex”, at the distal end of the needle which
regulates the secretion process. The translocation pore or the “translocon” is the
crucial element of the tip complex for the delivery of eﬀector proteins into the host
cell [65].
S. Typhimurium employs two type III secretion systems, namely the T3SS-1 and
T3SS-2, encoded within the SPI-1 and SPI-2 pathogenicity islands respectively. The
T3SS-1 is spatio-temporally coordinated to ensure that it is synthesized only when
the bacteria needs to invade the host cells [66]. The ensuing contact with the host
cell acts as an activating signal for the secretion of the T3SS substrates [67, 68].
There are two gene clusters within SPI-1 responsible mainly for coding the structural components of the secretion machinery, namely the inv-spa and the prg-org
clusters. Between these two clusters lies the sic-sip gene cluster which encode the
major SPI-1 eﬀector proteins and their chaperones [66].
The ﬁrst gene of the inv-spa cluster, invH, encodes a lipoprotein which is critical for
positioning InvG in the outer membrane [69,70]. InvG is one of the major component
of T3SS-1 basal body [71] and forms the outer ring, and hence is essential for the
secretion machinery to operate, as no needle structure was detected in a ΔinvG strain
[72]. InvE which is homologous to Yersinia YopN, was shown to control the secretion
of substrates by interacting with the SipB-SipC complex [73]. InvA is an integral
membrane protein which forms the export gate, and its C-terminus is responsible for
recognizing species-speciﬁc substrates for secretion [53]. InvB has been characterized
as a T3SS associated chaperone for the eﬀector proteins SipA, SopE, SopE2 and
SopA [74–77], demonstrating the same protein can function as chaperone for multiple
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substrates. InvC is the conserved ATPase of the T3SS-1 system providing the energy
necessary for secretion [78]. InvJ is a regulatory protein which acts as the molecular
ruler [79] of the T3SS-1 needle complex and along with PrgJ mediates substrate
switching [80]. In the ΔinvJ mutant, the needles are abnormally long and nonfunctional [81]. The SpaP, SpaQ, SpaR and SpaS proteins form the export machinery
along with the InvA and InvC [82].
The prg (PhoP-repressed genes) genes were ﬁrst identiﬁed as a group of genes
repressed in a mutant strain with constitutively active PhoP (pho-24 mutant) of the
phoP/phoQ two component system (TCS) [83]. Among them, PrgH and PrgK form
the inner ring of the basal body [84]. PrgJ is the inner rod protein which links the
needle to the base, and regulates substrate switiching and the needle length [80],
while PrgI is the needle protein [81]. The org (oxygen-regulated genes) genes orgA
and orgB are transcribed from the upstream prgH promoter and code for proteins
OrgA and OrgB which are key elements of the cytoplasmic components of the basal
body [85].
Although the components of T3SS-2 system are not as well characterized as those
of T3SS-1 [86], role of several structural proteins are deﬁned. SsaV is integral component of the inner ring of the secretion system [87], whereas SseB, SseC, and SseD
are the substrates of T3SS-2 and form the translocon [88]. SsaN is the ATPase of
T3SS-2 system [89].

1.3.4

Eﬀectors of Type III Secretion Systems

As mentioned previously, the eﬀectors of the T3SS-1 mediate the entry of the bacterium into the non-phagocytic host cells, marking the initiation of infection process;
whereas those translocated via the T3SS-2 are crucial in the intracellular survival
of the bacterium. Most T3SS-1 eﬀectors are encoded within the SPI-1, whereas
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some that are translocated via the T3SS-1 are encoded in the regions of chromosome
outside of SPI-1 [90]. Collectively, these eﬀectors trigger a cascade of biochemical
reactions in the host cell which ultimately lead to the internalization of bacteria by
the non-phagocytic epithelial cells [91]. Interestingly, their function is largely limited
to mediating the entry into epithelial cells, as the SPI-1 mutant infected intraperitoneally is still able to attach to the cultured cells and cause systemic disease in
mice [92].
Among the eﬀectors of the T3SS-1, the Sip (Salmonella invasion protein) proteins
SipA, SipB, SipC and SipD are encoded by the sip operon and are among the most
crucial proteins mediating invasion [93]. These proteins have a high degree of sequence homology with the Ipa proteins from Shigella [94, 95]. SipA modulates actin
ﬁlament polymerization by directly binding to this host protein, reducing the critical
concentration and inhibiting the depolymerization [96]. Moreover, SipA facilitates
the bacterial entry by increasing the actin-bundling activity of the host protein Tplastin [97]. SipC is a component of the T3SS-1 translocon and is able to insert into
the host membrane as soon as 15 minutes post infection [98]. In addition to this, it
also has a role as a bona ﬁde translocated eﬀector, where it mediates actin bundling
and nucleates actin polymerization [99, 100]. SipB is critical for the formation of the
translocon complex along with SipC [98, 101]. SipD is the tip protein which interacts with the needle protein PrgI to form the needle complex to inﬂuence eﬀector
secretion [102, 103].
SopE is the guanine nucleotide exchange factor (GEF) for the host small GTPases
Cdc-42 and Rac-1 [104], while the closely related SopE2 is the GEF only for Cdc42
[105] thus activating these G-proteins to initiate the biochemical cascade ultimately
resulting in the formation of specialized membrane structures called “ruﬄes” which
mediates the bacterial uptake. SopB is encoded by a gene located in SPI-5 [106], and
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is a phosphatidylinositol phosphatase which promotes membrane ruﬄing and thus
the bacterial internalization [107, 108]. This property of SopB is also enhanced by its
activation of SH3-containing guanine nucleotide exchange factor (SGEF), an upstream
exchange factor for RhoG [109]. SptP is a tyrosine phosphatase and also acts as the
GTPase activating protein (GAP) for Cdc42 and Rac1, reversing the biochemical
eﬀects initiated by the invasion proteins and hence mediating the recovery of normal
actin architecture [110, 111].
SopA is an E3 ligase for ubiquitination [112] and along with other major invasion
proteins, also plays a role during bacterial entry [113]. Further, this multifunctional
protein has also been demonstrated to promote neutrophil inﬁltration [114].
Apart from the above mentioned eﬀectors which have roles in the invasion process,
the SPI-1 encodes eﬀectors which function in other aspects of Salmonella pathogenesis. For instance, AvrA inhibits the host immune response, and has been proposed
to mediate bacterial survival within macrophages by suppressing apoptosis and thus
preventing early bacterial dissemination [115].
Once Salmonella successfully enters into the host cell, it switches its attention to
maintaining a replicative niche inside the host in the form of a specialized membrane
bound compartment known as the Salmonella containing vacuole (SCV) [116]. As
indicated previously, this phase of the life cycle is mediated by the action of a panel
of eﬀectors secreted through the T3SS-2 [117]. The T3SS-2 is known to translocate at
least 28 eﬀectors from within the SCV into the host cytosol. The primary functions of
these are to modulate intracellular growth, and are essential for intestinal as well as
disseminated infection [118]. As in the case of T3SS-1 secreted eﬀectors, these have
diverse functions. Most are known to have enzymatic activities, whereas a subset of
them behave as adaptors inﬂuencing the functions of their target host proteins [118].
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Although there are multiple eﬀectors being translocated through T3SS-2, SseF
and SseG are the only two eﬀectors which are encoded by the SPI-2 [119]. These are
present as core eﬀector proteins in all serovars and mediate the tethering of SCV to
the Golgi network [35] by forming a complex with the host protein ACBD3 [120]. The
localization of SCV near to the Golgi network is key as it contributes to acquisition
of nutrients and host membrane components during the maturation of the bacteria
containing vacuole [121]. Moreover, these two eﬀectors play a critical role during
intracellular growth inside host macrophages [119], or in vivo mice infection [35]. Another core eﬀector, SifA, is multifunctional and maintains vacuolar integrtiy [122],
as well as reduces the toxic lysosomal activity for which binding with its target
SKIP is required [123]. Consequently, a sifA mutant releases to the cytosol from
the SCV. In an epithelial cell, the sifA mutant can hyper-replicate [124], whereas
in the macrophages, it induces pyroptosis [125]. SifA also contributes to the formation of long specialized tubules originating from the SCV originally termed SIFs
for Salmonella Induced Filaments [126, 127]. These structures along with other similarly induced interconnected tubular systems have since been renamed as SITs or
Salmonella Induced Tubules [128]. The proposed function for these systems is aiding
nutrient acquisition for the intracellular bacteria owing to the increased surface area
due to tubulation [129].
SseJ and SopD2 appear to antagonize the membrane stabilizing role of SifA [130,
131] as these were responsible for destabilizing the vacuole membrane in the absence
of SifA. SseJ is an acyltransferase which is located at the cytosolic face of SCV
and esteriﬁes cholesterol to modulate the lipid content and hence the stability and
ﬂuidity of the SCV membrane [132]. This also presumably results in the accumulation
of lipid droplets in the host cell cytosol [133]. The deubiquitinase activity of SseL
mediates clearance of these lipid droplets by either degrading them or inhibiting their
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formation [134]. Moreover, SseL also inhibits the autophagy pathway by removing
ubiquitin from the host cytosolic aggregates formed post-infection [135]. SopD2 binds
to and inhibits the nucleotide exchange of host small GTPase Rab7 [136] and is a GAP
for Rab32 preventing its accumulation on the SCV thus contributing to restricting
vesicular transport and endosome to lysosome traﬃcking [137]. PipB2 tethers kinesin1, a host microtubule motor protein to the SCV membrane, which is activated by
SifA, thus resulting in anterograde extension of SCV and formation of SITs [138].
SteA is known to bind to host phosphatidylinositol 4-phosphate (PI[4]P) [139], and is
responsible for the partitioning of SCV membrane [140], which results in an individual
vacuole enclosing a single bacterium. SpiC, which is also a component of the T3SS-2,
inhibits phagolysosome formation [141] by targeting Hook3 protein of the host [142].
Salmonella therefore dedicates multiple eﬀectors, mainly translocated via T3SS-2, in
modulating the stability of the SCV membrane and also co-opting the host traﬃcking
system.
SteC is a kinase, and mediates the assembly of F-actin meshwork around the
SCV [143], whereas SpvB, a virulence plasmid encoded protein ADP-ribosylates Gactin to prevent actin polymerization [144].
GtgE is a speciﬁc cysteine protease that targets Rab32 as well as Rab29 and
Rab38 [145]. This eﬀector is absent in serovar Typhi, and thus is attributed to
the strict requirement of human host for this serovar, since Rab32 is shown to be
the host factor responsible for preventing the growth of serovar Typhi in murine
macrophages [146].
There are several eﬀectors, interestingly most of which are secreted both via the
T3SS-1 and T3SS-2 which play anti-inﬂammatory roles by suppressing host innate
immunity [118]. PipA, GogA, GogB, GtgA, SpvD and SseK2 have been shown to
inhibit host NF-κB signaling [147–149], whereas SpvC inhibits the MAPK signaling
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pathway [150]. SseK1 and SseK3 in addition to inhibiting the NF-κB signaling also
inhibits necroptosis in the host [151, 152].

1.4

Regulation of Virulence Determinants

1.4.1

Regulators of Bacterial Invasion

Various factors including bacterial proteins and environmental signals are responsible for regulating the process of bacterial invasion [153].
HilA is the master regulator of bacterial invasion and belongs to the OmpR/ToxR
family of transcriptional activators [154]. The central role played by this protein in
bacterial invasion is emphasized by an observation that a hilA deletion phenotype is
similar to deletion of whole SPI-1 locus [155]. HilA directly binds to the promoters
of the prg/org and inv /spa operons to activate them [156]. Furthermore, it is shown
to transcriptionally activate the expression of SopB, a key T3SS-1 eﬀector [157].
InvF belongs to the AraC family of regulators [71]. Its expression is primarily
activated by HilA [158], although HilA-independent mechanisms have also been reported [159]. InvF and a chaperone protein SicA acts together to mainly activate
eﬀectors of the sic/sip operon [160].
HilC and HilD are encoded within the SPI-1 [161] and along with RtsA, control
the expression of HilA [162]. All three regulators belong to the AraC/XylS family
and bind to the hilA promoter as well as their own respective promoters for self
activation [155]. HilD is the major activator of HilA, and along with the other two,
ampliﬁes the signal for hilA transcription [163]. Moreover, HilD and HilC can also
activate invF expression by binding to an alternative promoter [159].
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FliZ is primarily associated with regulation of ﬂagella expression, but is also known
to post-transcriptionally increase HilD level in the cell, thus acting as a positive
regulator of invasion [164].
The BarA-SirA two component system also has an input in bacterial invasion [165].
SirA is the response regulator which activates hilA transcription in the presence of
HilD [155]. SirA mediates its action by upregulating the expression of csrB and csrC,
which code for small RNA molecules that are inhibitory to an RNA binding protein
CsrA [166]. CsrA is a negative regulator of invasion as it binds to hilD mRNA to
block its translation [167].
HilE is the negative regulator of bacterial invasion, and it acts by directly binding
to and hence blocking the HilD activity which results in the negative regulation of
HilA [168].
FimZ is another negative regulator of the invasion machinery as it directly binds
and activates the hilE promoter [169]. Further, this protein is also know to negatively
regulate bacterial motility by repressing the ﬂagellar ﬂhDC operon [170].
H-NS is the major nucleoid-associated protein (NAP) which represses several genes
involved in bacterial virulence by binding to DNA at or near the promoter region [171].
Among the regulators of invasion, H-NS represses expression of HilA, HilD, HilC, and
RtsA [172]. Moreover, H-NS is also known to repress genes other than those involved
in invasion. Interestingly, among these other genes are some SPI-2 genes such as ssaB,
ssaG, ssaM, and sseA [173]. Apart from H-NS several other NAPs also contribute
to regulation of diverse virulence genes. Hha synergistically aids H-NS mediated
repression of hilA, hilC and rtsA [172, 174]. Similarly, YdgT negatively regulates the
SPI-2 genes by acting synergistically with Hha [175]. Integration host factor (IHF)
is an NAP that acts as an activator of invasion during the logarithmic growth phase
at the level of HilD [176]. Similarly, Fis activates invasion genes by inﬂuencing hilD
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transcription [177]. Moreover, this global regulator also activates multiple genes from
the SPI-2, SPI-4, and SPI-5 loci [178, 179].
There are still other proteins that play regulatory functions during invasion. RtsB
inﬂuences SPI-1 gene expression by negatively regulating FliZ [180]. Lrp is a negative
regulator of most virulence genes such as hilA, invF and ssrA [181]. Lon protease
is a heat shock protein that negatively regulates hilA transcription [182]. Whereas
the chaperone complex of DnaK/DnaJ antagonizes the Lon activity and promotes
invasion [183]. Fur is a positive regulator of invasion due to its repression of hns gene
expression [184].

1.4.2

Regulators of Intracellular Survival

The SsrA-SsrB two component system is the master regulator of the SPI-2 gene
expression responsible for intracellular bacterial survival and mouse virulence [185].
SsrA is the sensor kinase and SsrB is the response regulator of this system [186].
SsrB facilitates the induction of SPI-2 genes by relieving transcriptional repression
mediated by H-NS [173]. Interestingly, in a splendid example of cross talk between
the SPI-1 and SPI-2 systems, HilD binds to the regulatory region downstream of
ssrAB promoter to displace H-NS and induce expression of multiple SPI-2 genes [187,
188]. Moreover, SsrB has been recently shown to repress SPI-1 expression through
its actions on hilA and hilD transcription [189].
The OmpR regulator from the EnvZ/OmpR two component system activates the
ssrAB transcription by directly binding to the promoter following entry into the
macrophages [190]. Furthermore, SlyA is another regulator that modulates intracellular survival and virulence by stimulating ssrA transcription [191].
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1.4.3

phoQ/phoP Two Component System

The phoP gene was originally described as a regulator of nonspeciﬁc acid phosphatase (PhoN) expression [192]. However, its role in bacterial virulence was ﬁrst
characterized in 1989 as the one encoding a protein that protects the bacteria from
the action of host antimicrobial peptide defensin [193]. In the same year, Miller
et al., showed that this is a two-component regulon comprising of the periplasmic
domain containing sensor kinase PhoQ which phosphorylates and activates the response regulator PhoP. Moreover, they identﬁed in this study a gene pagC which
was required for virulence in mice and intra-macrophage survival [194]. Still in 1989,
the two-component nature of the system and its role in transcriptional regulation of
psiD gene in response to phosphate availability was demonstrated independently by
Groisman et al., [195].
The fact that pag genes are transcriptionally activated when the bacteria is inside
the macrophages was observed when as many as eight proteins were absent in a phoP
mutant as opposed to the wild type following macrophage uptake [196]. Further, it
was observed that the activation of certain pag genes occurred maximally when the
environment inside the macrophage became acidic (pH<5) and not when the bacteria
were inside the vacuoles in epithelial cells [197]. However, a later study indicated the
signals activating pag genes might be similar in both cell types [198]. Moreover, it
was known later that the pH mediated induction of these genes is independent of the
phoP/phoQ system, since the activation was noted even in phoP and phoQ mutants
[199, 200]. Nevertheless, this suggested that the change in the microenvironment
encountered by the bacteria can induce a switch in gene expression proﬁle.
In an interesting ﬁnding, Miller et al., observed that constitutive expression of
PhoP (PhoPC phenotype) owing to the pho-24 mutation [192] in the phoP/phoQ
locus, would have a detrimental eﬀect on Salmonella virulence to a similar extent to
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a phoP deletion mutant. They observed the level of multiple proteins being repressed
in the PhoPC phenotype and thus termed the genes encoding them collectively as
prg (phoP -repressed genes) [83]. Further, this virulence phenotype associated with
the PhoPC strain was seen to require the presence of plasmid encoded spv gene
products [201]. However, it was later demonstrated that the PhoPC phenotype does
not involve the phoP gene per se nor it results in constitutive expression, as the
phenotype was attributed to a single amino acid substitution (T48I) in PhoQ resulting
in increased kinase activity [202]. Further, this mutant form of PhoQ required much
higher concentration of Ca2+ in the environment in order to repress the transcription
of target genes [203].
In a landmark study, Behlau and Miller showed the phoP/phoQ locus oppositely
regulates bacterial invasion of epithelial cells and survival inside macrophages. Specifically, they found that one of the prg gene products PrgH which was repressed considerably in the PhoPC phenotype was essential to induce bacterial mediated endocytosis
in the MDCK epithelial cells. Expression of genes in the prg loci also appeared to be
repressed when grown under conditions inducible for pag gene activation [204]. This
further illustrated that appropriate regulation of a set of genes is key to virulence.
Two years later, the same group showed activated PhoP negatively regulates the
prgHIJK operon essential for eﬀector secretion, resulting in the signiﬁcant diﬀerence
in the secretion proﬁle and hence the consequential defect in the invasion phenotype
of these cells [205]. In 1996, Bajaj et al., found that the PhoP-mediated modulation
of invasion was mediated by regulating the expression of HilA [156].
The PhoP-PhoQ regulon has multiple eﬀects on bacterial physiology, as they are
known to regulate more than 1% of open reading frames of Salmonella genome [206].
These cellular processes include transport of Mg2+ [207], modiﬁcation of bacterial
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lipopolysaccharide layer [208, 209], resistance to host derived cationic antimicrobial
peptides [210–212], resistance to bile [213] and peptidoglycan remodeling [214].
The virulence defect attributed to phoP/phoQ mutant is partially mediated by
one of the PhoP activated genes mgtC. This gene is located within the SPI-3 locus and
the encoded protein MgtC primarily functions in acquisition of Mg2+ by the cell. This
protein therefore assures the availability of Mg2+ to the intravacuolar bacteria [215].
PhoP is a 224-amino acid protein with sequence similarity to other DNA-binding
transcriptional regulators of OmpR subfamily [216]. Whereas PhoQ is a 487-amino
acid sensor kinase that phosphorylates PhoP at the N-terminus in response to relevant
environmental signals by transferring a phosphate group from its autophosphorylated
histidine [217]. The regulon is autogenously regulated by its components PhoP and
PhoQ in a positive manner [218], facilitating the ampliﬁcation of signals sensed by the
sensor kinase. There are two promoters for the operon, one of them phoPp2 is constitutive, whereas the activation of the other one phoPp1 is triggered by low Mg2+ and is
PhoP-PhoQ dependent. Seemingly, the PhoP proteins that are present at basal levels are phosphorylated by PhoQ following environmental stimulation. The phosphoPhoP would then initiate a positive regulatory loop by activating transcription of
phoPp1 , leading to increased expression of pag gene products [199]. This two component system primarily responds to the periplasmic levels of the divalent cations Mg2+
and Ca2+ , leading to regulation of various cellular processes [199]. Notably, this system is activated by the very low (micromolar) levels of Mg2+ , whereas even millimolar
concentration is high enough to repress the transcription of the operon [219], presumably by triggering the dephosphorylation of phosphorylated PhoP by PhoQ [220].
The sensing of Mg2+ concentration by this system aids the bacteria to determine
its spatial location, where the intracellular microenvironnment is characterized by
a substantially low concentration of this divalent cation [221]. This causes the dif-
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ferential expression of genes required at diﬀerent phases of the bacterial life cycle
corresponding to diﬀerent stages of pathogenesis [222, 223].
The PhoP/PhoQ system hence illustrates an exquisite example of spatio-temporal
control of gene expression essential in pathogenic bacteria.

1.5

Inﬂuences of Long Chain Fatty Acids (LCFAs) in Bacterial Survival
External fatty acids of diﬀerent chain lengths can aﬀect the metabolism of bacteria

in diverse ways. For decades, the antimicrobial properties of fatty acids have been
demonstrated. The germicidal action of fatty acids on fungal growth was reported
as early as 1899 [224]. Burtenshaw in 1942 proposed an association between the selfdisinfecting nature of skin with the free fatty acids of long chain length [225]. The
inhibitory action of fatty acids can be attributed to the physico-chemical mechanisms.
In particular, the unsaturated fatty acids can alter the surface tension if accumulated
around bacterial cells thus signiﬁcantly aﬀecting the permeability of the surface [226].
It is observed in general that longer chain length and higher degree of unsaturation of
the fatty acid chains tend to increase this detergent-like inhibitory properties [227].
Lipids of diﬀerent forms are also known to activate the mononuclear phagocyte system. Speciﬁcally, triglycerides of various fatty acids [228] and polyunsaturated fatty
acids (PUFAs) [229] stimulate the phagocytic activity. Further, incorporation of unsaturated fatty acids supplied exogenously into the macrophage membrane enhances
its phagocytic activity by altering the membrane ﬂuidity [230,231]. Supplementation
of macrophage membrane with PUFAs also alters the physico-chemical properties
of lipid raft membrane domains and subsequently enhances the antibacterial properties [232]. Unsaturated fatty acids also trigger the diﬀerentiation of macrophages
into the M2 subtype which are more eﬃcient phagocytes [233, 234]. Some speciﬁc
long chain fatty acids play critical immunomodulatory roles. Arachidonic acid is
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one such polyunsaturated fatty acid which is a precursor for eicosanoid mediators
Prostaglandin and Leukotriene [235]. These metabolites are pro-inﬂammatory in nature and serves to eradicate pathogenic invaders [236].
The fact that presence of long chain fatty acids in the immediate vicinity can
have detrimental eﬀects on bacteria should prompt these pathogens to try and breakdown these biomolecules. This is accomplished via the fatty acid breakdown or the
β-oxidation pathway which maintains the lipid homeostasis [237]. In Salmonella and
in E. coli, the breakdown is catalysed by the enzymes of the fad regulon [238]. The
steps involved can be summarized as transport of long chain fatty acids into the
cell interior followed by activation and enzymatic cleavage generating molecules of
acetyl coenzyme A [239]. Transport of LCFAs from the external milieu across the
bacterial outer membrane towards the periplasm is facilitated by a membrane protein FadL [240]. The fatty acids are next transported to the cytosol across the inner
membrane by FadD, an acyl coenzyme A synthase [241]. The long chain acyl-CoA
is then converted to enoyl-CoA by the dehydrogenase FadE [242]. The enoyl-CoA
is hydrated followed by oxidation (dehydrogenation) mediated by FadB, and the ﬁnal step of thiolytic cleavage is catalyzed by FadA. The FadB and FadA proteins
form a tetrameric complex consisting of two copies of each molecule [243]. This complex displays ﬁve diﬀerent enzymatic activities. FadB alone mediates the epimerase,
isomerase, hydratase and dehydrogenase activity while FadA possesses the thiolase
activity [244]. This cycle is then repeated with the removal of one acetyl CoA from
longer acyl CoA molecule in each cycle [237].
Regulation of fatty acid degradation and its biosynthesis is mediated by FadR
protein Fig.1.1. This molecule acts as a transcriptional repressor of the degradation
pathway [238] by binding to the operator of fad genes; while acting as an activator
of the biosynthesis pathway [246]. The long chain acyl CoA molecules are known
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Fig. 1.1. Fatty acid metabolism and regulation through FadR.
(Reprinted with permission from [245]).

to bind to the FadR protein, causing their release and hence the derepression of fad
genes [247, 248]. Overall, the regulation of fatty acid degradation and biosynthesis
pathways are sophisticated and ﬁnely tuned.

1.6

Small RNAs in Bacterial Virulence
Small non-coding RNAs (sRNAs) often also referred to as small regulatory RNAs

are molecules heterogenous in size (ranging from 50 to 500 nucleotides) and known
to post-transcriptionally regulate gene expression in bacteria [249]. These charac-
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teristically belong to a speciﬁc regulon and are typically able to modulate multiple
targets resulting in a global control mechanism [250]. Commonly, the mode of action
for these molecules is to base pair with the target mRNA entities, causing an altered
expression by aﬀecting the stability or translation of the target molecules [251]. The
antisense activity can be either cis- (when it is encoded from the opposite strand)
or trans- when the target loci are physically unlinked [252]. The pairing, specially in
trans-acting molecules is usually discontinuous and relatively short, consequently its
formation is fast. Further, diﬀerent regions within a single sRNA molecule can pair
with multiple targets [253]. The response mediated by these molecules are therefore
rapid and are particularly suited to respond to sudden environmental changes the
bacteria might encounter during the various phases of its life cycle [254]. For most
virulent bacteria this underscores the transition between saprophytic and pathogenic
lifestyles [255]. These molecules therefore add another layer to the complex interplay
between various factors involved in gene regulation [256].
For many years, the roles of regulatory RNA in bacterial pathogenesis went unappreciated. RNAIII in Staphylococcus aureus was considered a paradigm for RNA
species modulating bacterial pathogenesis, where it was known to act as antisense
regulator of Staphylococcus virulence factors [257]. In recent years, owing largely
to the rapid development of biocomputational methods for prediction and screening
technologies such as tiling arrays and RNA-seq, there has been intensive studies and
discoveries linking sRNAs and bacterial pathogenesis [258]. Since sRNAs are particularly useful in mediating rapid response in gene expression, one instance where these
are proven to be crucial is when bacteria are subjected to various stress conditions or
environmental insults when they enter the host [259]. Also of special importance is the
role of RNA-binding proteins such as Hfq and CsrA, which work in close conjunction
with numerous sRNAs to regulate diverse aspects of bacterial pathogenesis [260,261].
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Hfq-associated small RNAs play a vital role in Salmonella pathogenesis. In a
study, it was found that more than half of all known Salmonella secreted proteins
could be targets for these small RNAs [262]. Some well characterized sRNAs in
Salmonella relevant to pathogenesis include InvR, SgrS, IsrJ, IsrM, PinT and CsrB/C
[263]. InvR was the ﬁrst small RNA discovered from a pathogenicity island (SPI1), and functions to regulate porin synthesis [264]. IsrM is another island encoded
sRNA that regulates both the invasion and intracellular survival phase of virulence
by targeting hilE and sopA mRNA [265]. SgrS is a dual-functioning core-genome
encoded conserved sRNA which represses the expression of sopD mRNA [266]. The
prophage encoded IsrJ mediates host cell invasion by regulating translocation of SPI1 eﬀector SptP [267]. PinT is a PhoP-activated sRNA that represses the expression
of sopE /sopE2 encoding the GEFs responsible for bacterial invasion, and also crp
(cyclic AMP receptor protein) which activates several virulence genes during the
infection process [268]. CsrB and CsrC are redundant regulators and antagonize the
action of an RNA-binding protein CsrA which has pleotropic eﬀects in Salmonella
virulence [166, 167].
Given the diverse role they have in bacterial gene regulation, an in depth study
could well elucidate novel mechanism of virulence control by these molecules.

1.7

Small Proteins
In recent years, small proteins have been elucidated as an important group of

molecules capable of orchestrating a wide range of cellular processes in bacteria [269].
By convention, small proteins are deﬁned as those with 50 or less amino acids. They
are also diﬀerent from small peptides resulting from the cleavage of larger precursor
proteins [270]. Although ubiquitous, these molecules have traditionally been understudied, due to limitations in biochemical, genetic and bioinformatic studies owing to
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their size [271]. These can be broadly grouped into the non-secreted ones which may
be cytoplasmic or membrane-associated and mostly play regulatory roles in cell physiology and the secreted ones which mainly function in interbacterial communication
such as quorum sensing autoinducer peptides or competition such as bacteriocin [272].
The diverse cellular processes modulated by the non-secreted small proteins typically involve spore formation (in Bacillus subtilis) [273, 274]; cell division [275–277];
signal transduction [278, 279]; transport [280–282]; regulation of enzymatic activity
of membrane bound proteins [283–285] and chaperone function [286, 287].
Due to the small size of these proteins, the number of activities they can have
is limited. For instance, these are very unlikely to have any enzymatic properties.
These molecules therefore preferably function in mechanical manner. One example
of such protein is MciZ (mother cell inhibitor of FtsZ), which inhibits the activity
of tubulin like protein FtsZ, a major component of the protein complex mediating
cell division in bacteria [288]. From a yeast two-hybrid screening, MciZ was found to
directly bind to and thus block the GTP-binding domain of FtsZ, hence inhibiting
FtsZ polymerization. This resulted in prevention of unwanted cell division during
sporulation [275]. Similarly, MgrB is a small protein which negatively regulates the
PhoQ/PhoP system in E. coli [289]. In this study, the authors noted that deletion of
mgrB increased the transcription activity of its own promoter, whereas overexpressing
MgrB from a plasmid would repress the transcription. Since the PhoQ/PhoP system
was known to regulate mgrB expression [290], they tested whether MgrB would interact with the two-component system. They were able to demonstrate that MgrB
would indeed bind and repress PhoQ activity, as a result of the negative feedback
loop. In 2016, Salazar et al., observed that MgrB modulates the bifunctional activity
of E. coli PhoQ to regulate the partial adaptation of PhoP dependent genes [279].
Sda is another cytosolic small protein which blocks the interaction between diﬀerent
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kinases involved in B. subtilis sporulation and even between diﬀerent domains of a
single protein [291].
Interestingly, interplay between a small protein and its target can promote interaction between domains or proteins. In one example, MgtR, a 30-amino acid
small protein in Salmonella assists the protease activity of an AAA+ protease FtsH
to degrade the virulence factor MgtC [285]. MgtR was shown to directly interact
with MgtC thereby facilitating its degradation by FtsH. This occurs presumably by
changing the structure of MgtC, hence rendering it sensitive to the protease. Similarly MntS, a 42-amino acid small protein in E. coli is known to optimize the Mn2+
concentration inside the cell by inhibiting the export of this cation by the transporter
MntP [286]. Morever, some small proteins are proposed to function as chaperones for
small RNAs. In a study, Smaldone et al suggested that a small protein FbpB may
aid the activity of a small RNA FsrA by acting as a chaperone [292].
In the following chapters of this dissertation, we provide evidence for a small
protein YshB playing a regulatory role in diﬀerent aspects of Salmonella virulence.
This ubiquitous small protein constitutes of 36 amino acids and was annotated in
a screen based on presence of ribosome binding sites [293], and later validated as a
protein expressing gene in E. coli [294].
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2. A SMALL PROTEIN YSHB WITHIN A PREDICTED
SMALL RNA STNC1450 LOCUS MODULATES
SALMONELLA VIRULENCE
2.1

Abstract
Bacterial small non-coding RNAs (sRNAs) are known to modulate expression of

virulence genes to withstand host defenses during infection. Therefore, we hypothesized that the small non-coding RNAs in Salmonella play a key role in its pathogenesis. In order to test our hypothesis, we ﬁrst constructed a deletion mutant library of
putative Salmonella sRNAs in strain SL1344, and characterized the mutants by conducting assays to assess their eﬃciency on invasion of host epithelial cells. Altogether,
52 knockout strains were assessed for their invasion eﬃciency in HeLa cells. However,
none of the deletion mutants displayed any signiﬁcant phenotype, therefore, we exogenously expressed some of the sRNAs from an arabinose inducible plasmid in the
wild type strain. From this, we found that induction of sRNA STnc1450 signiﬁcantly
reduced the invasion eﬃciency. However, the genomic location of STnc1450 showed
that there was a small open reading frame within the predicted sRNA encoding gene
named yshB. This led us to suspect that the phenotype might have been due to the
induction of either the protein or the small RNA. We were able to demonstrate that
the phenotype was in fact due to the induction of small protein. More importantly,
we showed that YshB is important during the intracellular phase of the bacterial life
cycle and plays a signiﬁcant role in mice virulence. Furthermore, we found yshB expression was higher when the bacteria were grown under SPI-2 inducing conditions or
when inside host macrophages. Consequently, we propose the induction of this small
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protein in Salmonella mimics intracellular conditions and hence acts as a signal to
switch the down-regulation of the invasion machinery.

2.2

Introduction
Pathogenic bacteria have evolved complex regulatory circuits to tightly regulate

the expression of virulence genes. Commonly, this is achieved by turning on or oﬀ
a certain repertoire of genes once the pathogen reaches either a speciﬁc site in the
host, or after a certain period of time post infection. This is evidently the case in
Salmonella, which ﬁrst has to actively participate in the invasion followed by a lengthy
intracellular phase of survival and replication within the host cells.
The invasion of the non-phagocytic epithelial cells of intestine is principally mediated by the eﬀectors of Type III Secretion System-1 (T3SS-1). Apart from the
direct role of these secreted eﬀectors in mediating invasion, an elaborate network
of regulatory proteins also play a vital role in regulating the expression of invasionrelated genes [153]. Essentially, the expression of these genes is governed by the
signals from external environment; in this case, the distal small intestine of the infected host [295]. The invasive phase is succeeded by sustenance and multiplication
inside the host cells within a specialized compartment called the Salmonella Containing Vacuole (SCV). This is mediated primarily by the components of the Salmonella
Pathogenicity Island-2 (SPI-2) system. This spatio-temporal regulation of virulence
gene expression is critical for Salmonella mainly because most of the eﬀectors are
committed to either the invasive or the replicative phase of the life cycle. Although
it is known that some eﬀectors have a multi-faceted role in modulating these diverse
phases [296].
Salmonella is able to sense cues from its immediate environment as a means to
switch the expression of particular sets of genes. Depending on where the bacteria
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are located, these signals might vary. For instance, the site of invasion into the host
cells is the distal intestine. Therefore, the immediate environment at this site which
is low oxygen and high osmolarity triggers the induction of SPI-1 genes. This results
in the synthesis of the invasion machinery, which renders the bacteria competent for
actively entering host enterocytes. Once the bacteria successfully enter the host cells
and reside within the vacuole, the chemical composition of the microenvironment
encountered is diﬀerent as opposed to when they are extracellular. Particularly when
the bacteria are engulfed by the macrophages, the intraphagosomal environment is
predominantly one with low cation concentration and mildly acidic pH. These cues
are necessary to switch the preference towards the intracellular adaptation, so that
diﬀerent sets of genes are induced to suit the needs.
More importantly, this ﬁne-tuning for the switch is necessary from multiple stand
points, as gene expression at unwanted times is not only redundant or energy expensive but also detrimental. One example is SipB, a major protein mediating invasion,
which is also known to induce programmed cell death in macrophages [297]. Consequently, when the bacteria reside within the host macrophage cells, it maneuvers the
regulation machinery to repress the genes essential for invasion. Hence, there is some
degree of inverse regulation between the invasive and survival phases.
Interaction of Salmonella with its host cells has consistently been a fascinating
subject of inquiry for many decades now. Owing to some recent exciting discoveries
due mainly to the technological advancements in the ﬁeld of RNA sequencing and in
silico approaches [265, 298, 299], we made an eﬀort to assess the role of small RNAs
in Salmonella virulence. While doing so, in a rather exhilarating case of serendipity,
we functionally characterized a small protein YshB to establish its role in bacterial
virulence.
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In this chapter, we present evidence for the role of a novel small protein YshB
as a modulator of the switch to trigger adaptation to the intracellular phase of the
bacterial life cycle.

2.3

Materials and Methods

2.3.1

Bacterial strains and mammalian cell lines

Isogenic derivatives of virulent wild-type (WT) SL1344 strain of Salmonella Typhimurium were used in this study [300]. In-frame chromosomal deletions of genes
and chromosomal ﬂag tagged constructs in Salmonella strains were generated by the
one-step gene disruption strategy [301, 302] using the λ-Red recombination system.
Salmonella and E. coli strains were routinely grown in Luria-Bertani (LB) broth. For
the induction of SPI-1 machinery, Salmonella strains were grown in LB broth with
0.3 M NaCl ﬁnal concentration. N-salts minimal medium with low Mg2+ concentration (SPI-2 media) was used for the induction of SPI-2 components [303]. Antibiotics
when needed were used at the following concentrations: Streptomycin (150 µg/ml),
Ampicillin (120 µg/ml), Kanamycin (40 µg/ml) and Tetracycline (15 µg/ml).
The mammalian cell lines HeLa (CCL-2) and RAW 264.7 were purchased from
ATCC 120 (Manassas, VA), and maintained in Dulbecco’s modiﬁed Eagle’s medium
(DMEM; VWR) supplemented with 10% fetal bovine serum (FBS; Gibco).

2.3.2

Plasmids

For the induction plasmids, PCR-generated amplicons were cloned into
EcoRI/XmaI sites of an arabinose inducible plasmid (pZP1137) so that it was in
frame with the M45 tag at the C-terminus. Plasmid pM1644 expressing SipA fused
to TEM-β-lactamase was used for translocation assay [304]. Since YshB is a 5
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kD protein, in order to facilitate its visualization by Western blot, a translational
fusion with an M45-TEM double tag fragment derived from pM1644 was made to
the C-terminal end of YshB in pZP1137 by subcloning to generate plasmid pyshB
(pZP3628).

The resulting YshB-M45-TEM protein expressed from this plasmid

had a molecular weight of 35 kD. The same M45-TEM tag was also subcloned
into the empty vector (pVector-TEM; pZP3635) and used as a control. Another
vector control pVector-EGFP (pZP3636) was constructed by subcloning the 759
nucleotide fragment generated from XmaI/XbaI digest of pEGFP-N2 into the same
sites of pZP1137. To construct a plasmid in which yshB would be expressed from its
native promoter (pyshBnp; pZP3637), a 254 nucleotide fragment was ampliﬁed from
Salmonella genome including 130 nucleotides upstream of yshB, which included its
native promoter. This fragment was cloned to the XmaI site of the vector control
plasmid (pVector-EGFP). The resulting YshB-EGFP protein expressed from this
plasmid had a molecular weight of 31 kD. To construct the plasmid pyshBnoATG
(pZP3399), the forward primers were designed so that the ATG for yshB was
omitted. The PCR product thus ampliﬁed was then cloned to the EcoRI/XmaI sites
of pZP1137. Plasmid pyshBfs (pZP3400) was constructed by designing a primer in
which the ﬁrst adenosine nucleotide for yshB was omitted which resulted in a shifting
of the reading frame. Moreover, plasmid pyshBdg (pZP3634) was constructed by
annealed oligo cloning of a degenerate oligonucleotide sequence coding the same 36
amino acids of YshB into the EcoRI/XmaI sites of pVector-TEM. For expression
within the macrophages, the respective genes were subcloned to a plasmid with a
SPI-2 induced promoter ProsseA, pZP545 [305]. Furthermore, a plasmid used for
co-transformation with pM1644 was constructed by subcloning the 2308 nucleotide
fragment from pyshB containing YshB-M45-TEM along with the araC and ParaBAD
regions for arabinose induction to the ClaI/Hind III sites of pACYC-184SK plasmid
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to generate plasmid pyshB -TEM ACYC (pZP3638). The sipA gene of pM1644 was
replaced with yshB by subcloning to generate plasmid pyshB-TEM’ (pZP3639)
which was used to assess translocation of YshB into the host cells.

2.3.3

Invasion Eﬃciency

The invasion eﬃciencies were assessed by classical gentamicin protection assay
[306]. In brief, overnight LB-broth cultures of Salmonella were sub-cultured after a
1:30 dilution at 370 C in 0.3M NaCl LB-broth to an OD600 of 1.0. HeLa cells were
then infected at an MOI of 10 in a 24-well plate and incubated for 15 minutes at 370 C
in a 5% CO2 -incubator. After infection, cells were washed thrice with PBS followed
by addition of DMEM containing 100 µg/ml of gentamicin to each well and further
incubated for an hour to kill extracellular bacteria. Cells were washed again three
times with PBS and lysed with 0.1% sodium deoxycholate. Cell lysates were then
serially diluted and plated on LB plates for colony enumeration the next day.

2.3.4

Intracellular Survival Eﬃciency

Bacterial infection of RAW264.7 macrophages and intracellular survival assays
were carried out by gentamicin protection assay as described previously [307]. Brieﬂy,
the bacterial cultures grown to an early stationary phase were diluted to an OD600
of 0.1. The bacteria were opsonized for 20 min in DMEM containing 10% normal
mouse serum (Gemini Bio-Products, Woodland, Calif.) at 370 C. Opsonized bacteria
were added to RAW264.7 macrophage cells at an MOI of 10 in a 24-well plate and
incubated for 30 min at 370 C in 5% CO2 for infection. This was followed by washing
the cells thrice with PBS and incubating further for an hour in DMEM with 10%
FBS and 100 µg/ml of gentamicin to kill extracellular bacteria. After one hour, cells
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were washed again three times with PBS and incubated for the required amount of
time in 16 µg/ml of gentamicin containing DMEM. At 2 and 18 h post infections, the
infected macrophages were washed three times in PBS and lysed with 0.1% sodium
deoxycholate. Samples were then serially diluted and plated onto LB plates for enumeration. The replication fold was determined by dividing the number of intracellular
bacteria at 18 h by the number at 2 h.

2.3.5

Competitive Index Assay

Bacteria were grown overnight at 370 C in LB medium. The bacteria were then
harvested by centrifugation and resuspended in sterile PBS. The wild type and
the mutant or the complemented strains were mixed at a 1:1 ratio based on their
OD600 values. Serial dilutions were prepared for each bacterial mix and plated onto
LB+streptomycin and LB + streptomycin + kanamycin plates to calculate the input
titre. On the LB+streptomycin plates, both wild type and mutant strains would
grow, whereas LB + streptomycin + kanamycin would act as selective media for only
the mutants. Around 104 cfu of bacteria in 200µl were injected intraperitoneally into
6- to 8-week-old female BALB/c mice (5 mice for each mixture sample). The mice
were sacriﬁced two days post infection by CO2 euthanasia followed by cervical dislocation. Spleen and liver from each mouse were harvested and homogenized using
Dounce homogenizer aseptically in sterile PBS. Serial dilutions of the organ suspensions were prepared and plated onto LB+streptomycin and LB + streptomycin +
kanamycin plates for output titre. The colonies were enumerated the next day and
Competitive Index (CI) calculated as the ratio between the mutant strain and the
wild type in the output divided by the ratio of the two strains in the input [308].
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2.3.6

Diﬀerential inside/outside staining

The ability of bacteria to invade host cells was also evaluated with the inside/outside diﬀerential staining assay as previously described [309]. Brieﬂy, HeLa
cells were infected with Salmonella at an MOI of 5 for 15 minutes. The bacteria which
remain outside the cells were identiﬁed using rabbit anti-Salmonella O-antigen and
visualized with anti-rabbit Alexa Fluor 488. This was followed by permeabilization
of cells with 0.2% Triton X-100 and staining all bacteria, including the ones inside,
with Texas Red (Molecular Probes). Host cell nuclei and bacterial DNA were stained
with 4, 6-diamidino-2-phenylindole (DAPI; Molecular Probes). The outside bacteria
would be diﬀerentiated as they appear green or yellow and the ones inside as red
when visualized under a double ﬁlter for both Alexa Fluor 488 and Texas Red. The
invasion eﬃciency was determined by enumerating percentage of cells with either 1-5
or more than 5 internalized bacteria per host cell. The experiment was performed in
triplicate, with approximately 300 cells counted for each sample.

2.3.7

Fluorescent F-actin staining

For the purpose of studying ruﬄe formation, F-actin staining assay was conducted
as described previously [310]. Brieﬂy, invasion primed Salmonella was used to infect
HeLa cells at a multiplicity of infection (MOI) of 10. After 15 minutes post infection,
the cells were washed with PBS and ﬁxed with 3.7% formaldehyde in PBS for 15 minutes. The mammalian cells were then permeabilized with 0.2% Triton X-100 in PBS.
Salmonella was stained using anti-Salmonella O-antigen (Difco), and visualized with
anti-rabbit Alexa Fluor 488 (Invitrogen), whereas F-actin was visualized by staining
with Texas-Red conjugated Phalloidin (Molecular Probes, Eugene, OR). Zeiss LSM
700 confocal microscope was used to take images.
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2.3.8

Growth/Motility

For growth rate measurement, overnight LB broth culture of bacteria was subcultured with 1:100 dilution onto 10ml LB broth and grown at 370 C in a shaker with
200rpm. Serial dilution of the culture was then plated every 40 minutes and colonies
enumerated. Swarm plate assay was performed to assess bacterial motility [311].
Brieﬂy, semi-solid LB plates (0.25% agar) with and without 1mM L-arabinose were
prepared. From the overnight culture of bacteria, 100 µl was inoculated onto 2.5ml
LB grown until mid-log phase (OD600 = 0.5-0.6). From this culture, 1 µl was plated
into the semi-solid agar plate and incubated at 370 C. The size of the halo around the
site of inoculation was measured every 30 minutes.

2.3.9

Adherence Assay

HeLa cells were treated with Cytochalasin D (Sigma), an inhibitor of actin ﬁlamentation at a ﬁnal concentration of 1 µg/ml for 30 minutes before infection [312]
to prevent bacterial internalization. Salmonella strains were added to thus treated
cells at an MOI of 10, and allowed for 15 minutes to adhere to the host cells. The
cells were then washed thrice with PBS to remove the unattached bacteria followed
by subsequent plating for enumeration.

2.3.10

Protein Translocation Assay

HeLa cells were infected with Salmonella strains carrying plasmids expressing
the β-lactamase fusions in a 96-well plate at an MOI of 10. CCF4-AM (Invitrogen,
Carlsbad, CA) was then added into the wells 15 min post infection and incubated
for 2 hours at room temperature. CCF4 which emits green ﬂuorescence is a βlactamase substrate and upon cleavage emits blue ﬂuorescence. Infected cells were
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then examined under the Zeiss LSM 700 confocal microscope to quantify the number
of green and blue cells. Experiments were performed in triplicate and approximately
300 cells were counted in each sample.

2.3.11

Immunoblotting

Strains were grown overnight in LB, followed by subculture the next day in respective media. The in vitro culture was then centrifuged at 10,000 x g for 5 minutes
and the cell pellets were lysed with 2x Laemmli sample buﬀer and boiled for 10min.
For the intracellular infection samples, the macrophage cells were lysed 12 hours post
infection with 0.1% sodium deoxycholate. This lysate was centrifuged at 500 x g for
5 minutes to remove cell debris. The supernatant was then centrifuged at 10,000 x
g for 5 minutes to collect the intracellular bacteria. The samples were run on a 10%
SDS-polyacrylamide gels and immunoblotted using respective antibodies. The SipA,
SipB, SipC and GFP primary antibodies were polyclonal rabbit, whereas the antiTEM and anti-Flag (Sigma) were mouse monoclonal. Rabbit anti-ICDH was used to
probe ICDH protein as the loading control.

2.4

Results

2.4.1

Induction of a small protein YshB positioned within a predicted
small RNA STnc1450 locus causes lowered invasion eﬃciency in
Salmonella Typhimurium

In order to characterize the role of small non-coding RNAs in Salmonella Typhimurium SL1344 mediated invasion of epithelial cells, we constructed several knockout mutants of these sRNAs in the SL1344 wild type background and analyzed the
eﬀects on invasion of epithelial cells. Altogether, 52 sRNA mutants were constructed
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following one-step gene disruption strategy [301] using the λ-Red recombination system, and were assessed for their invasion eﬃciencies by the classical gentamicin protection assay (Fig.2.1).

Fig. 2.1. Invasion eﬃciencies of various sRNA knock out mutants: The sRNA mutants were assessed for their invasion eﬃciencies
by gentamicin protection assay. The error bars indicate standard deviations from mean of three independent experiments.

None of the 52 deletion mutants displayed any signiﬁcant diﬀerence in the invasion
phenotype (Fig.2.1). Since regulatory factors often exert their functions upon “over”expression, we induced these sRNAs from an arabinose inducible plasmid in the wild
type strain. On conducting the gentamicin protection assay for invasion among these
strains, we found that induction of sRNA STnc1450 was able to signiﬁcantly reduce
the invasion eﬃciency of the strain compared to that of the wild type (Fig.2.2).
It is important to note here that upon addition of L-arabinose alone, we did not
see any debilitating eﬀect on the invasion eﬃciency of Salmonella (Fig.2.3), as was
reported previously [313].
Upon further analysis, the genomic location of STnc1450 showed a small open
reading frame within the predicted sRNA encoding gene named yshB (Fig.2.4).
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Fig. 2.2. Induction of STnc1450 causes lowered invasion eﬃciency in S. Typhimurium: Relative invasion rates of Salmonella
strains with induced small RNAs from an arabinose inducible plasmid. Gentamicin Protection Assay was performed on HeLa cells infected with Salmonella strains with the corresponding small RNAs.
The invasion eﬃciency of wild type strain with an empty vector was
normalized as 100. The data are the averages of three independent experiments with error bars indicating standard deviations from mean.
Asterisk indicates a statistically signiﬁcant diﬀerence compared to the
wild type with empty vector using the Students t-test with p value
indicated.

Given the presence of the small protein encoding open reading frame within the
small RNA tested, the phenotype might have been due to the induction of either the
protein or the small RNA. To test this, we constructed plasmids with full length of
the small protein (pyshB ); without the start codon (pyshBnoATG); with frameshift
mutation introduced by deleting the ﬁrst nucleotide (pyshBfs) and with degenerate
nucleotide sequence coding the same 36 amino acids of YshB (pyshBdg) (Fig.2.5).

37

Fig. 2.3. Addition of L-arabinose has no signiﬁcant eﬀect on
Salmonella invasion: Eﬀects of L-arabinose on invasion eﬃciency
of wild type Salmonella and wild type with empty vector was checked
by gentamicin protection assay. (ns: not signiﬁcant)

Fig. 2.4. Genomic location of STnc1450 in S. Typhimurium
SL1344 showing the presence of an open reading frame encoding a small protein YshB.

These plasmids were introduced into the wild type Salmonella and their invasion
were evaluated by gentamicin protection assay. We observed the deﬁcient phenotype
in the strains with induction of full length proteins, both with the wild type and
degenerate nucleotide sequences. The phenotype however was conspicuously absent
when the plasmids with no ATG or frameshift mutation were introduced (Fig.2.6A
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Fig. 2.5. Sequence information of modiﬁed yshB showing variations in wild type, degenerate, frame-shifted and no ATG
constructs.

and B). The expression of the protein was demonstrable by Western blot (Fig.2.6C).
This strongly indicated that the phenotype was due to the induction of small protein.
The relative invasion eﬃciencies upon YshB induction were also assessed by carrying out the inside-outside diﬀerential ﬂuorescence staining [309]. The results from
this further supported the invasion deﬁciency of the YshB induced strain. Interestingly, the mutant strain alone did not have any signiﬁcant change in invasion levels
(Fig.2.7).
One of the hallmark events of Salmonella invasion of epithelial cells is the formation of ruﬄes as a consequence of actin polymerization, actively mediated by the
bacterial eﬀectors [96]. Since we observed a decrease in invasion eﬃciency from the
invasion assays, we further analyzed whether YshB induction has any eﬀects on inducing ruﬄe formation by Salmonella. As evident from Fig.2.8, when YshB was
expressed exogenously, the bacteria induced formation of weaker ruﬄes as compared
to the wild type or the mutant strain.
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Fig. 2.6. Induction of a small protein YshB positioned within
the predicted small RNA STnc1450 locus is responsible for
the lowered invasion eﬃciency: A) Relative invasion rates of
Salmonella strains with YshB induced from an arabinose inducible
plasmid in wild type (SL1344) background evaluated by Gentamicin
Protection Assay. (B) Relative invasion rates were similarly assessed
for YshB encoded from degenerate nucleotide sequences, and with no
start codon or frame-shifted yshB. (C) Immunoblot showing the expression of YshB from pyshB and pyshBdg. The bacterial cell pellets
were subjected to SDS-PAGE followed by immunoblot with anti-TEM
antibody. For all the graphs, asterisks indicate a statistically significant diﬀerence with indicated p values, and three independent experiments were carried out with the mean + SD represented as error
bars.
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Fig. 2.7. Quantiﬁcation of Inside-outside diﬀerential staining
showing repression of invasion in YshB induced strain: Percentage of cells with either 1-5 or more than 5 internalized bacteria
was enumerated. Asterisk indicates a statistically signiﬁcant diﬀerence with indicated p value. Three independent experiments were
carried out with the mean + SD represented as error bars.

2.4.2

Induction of YshB has no eﬀect in adherence to host cells or the
growth and motility of the bacteria

Salmonella infection is initiated by attachment to the host cells. So any deﬁciency
in invading non phagocytic cells could be due to ﬂaw in the adhesion mechanism.
To test this, we conducted adherence assay with the YshB induced strain. In this,
bacterial entry into host cells is blocked by adding an inhibitor of actin polymerization.
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Fig. 2.8. YshB induction causes the formation of weaker rufﬂes on host cells: Following infection of HeLa cells with indicated
Salmonella strains at an MOI of 10 for 15 min, Texas Red (Red) conjugated Phalloidin was used to visualize F-actin accumulation whereas
bacteria were stained using rabbit anti-Salmonella O and a secondary
anti-rabbit AF488 conjugate (green) and images taken on a Zeiss LSM
700 confocal microscope. Ruﬄes are shown by encircling white dotted
lines.

The bacteria would therefore attach to the surface, but are unable to enter the host
cells. We found the defect in invasion on YshB induction was not due to any hindrance
in the adherence capability of bacteria to the host cells (Fig.2.9).
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Fig. 2.9. Induction of YshB has no eﬀect in adherence to
host cells: HeLa cells were treated with Cytochalasin D (1µg/ml
ﬁnal concentration) for 30 minutes before infection. Bacteria were
added to cells at an MOI of 10 and after 15 minutes were washed
and subsequently plated for enumeration (ns: not signiﬁcant). Error
bars indicate the standard deviation from mean of three independent
experiments.

Furthermore, the growth rate and motility of bacteria were also unaﬀected upon
YshB induction (Fig.2.10).

2.4.3

Predicted secondary structure for YshB

The 36 amino acids YshB was described as a small protein with a predicted transmembrane domain with unknown function in previous studies [294, 314]. From the
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Fig. 2.10. YshB induction does not aﬀect S. Typhimurium
growth and motility: (A) Growth rate of wild type and YshB
induced Salmonella strains in LB medium. (B) Swarming assay to
detect motility rates of Salmonella strains with induced YshB in LB
with 0.25% agar. Images were taken 7 hours post inoculation. (C)
Quantitative representation of the motility rates between wild type
and YshB induced strains as shown by diameter of the halo around
the spot of inoculation with time.

amino acid sequence, the secondary structure of this small protein was predicted using
PSIPRED online server (Fig.2.11), where the second helix constitutes the predicted
transmembrane domain.
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Fig. 2.11. Predicted secondary structure for YshB: (A) Amino
acid sequence information for small protein YshB.The residues in blue
constitute the hydrophobic stretch of the putative transmembrane
domain. (B) Predicted secondary structure for YshB using PSIPRED
(http://bioinf.cs.ucl.ac.uk/psipred/).

2.4.4

Induction of YshB reduces the levels of invasion proteins

The SPI-1 eﬀectors play key roles in mediating bacterial invasion. In order to
assess whether the level of major SPI-1 eﬀectors is altered in the cell due to YshB induction, we tested the levels of SipA, SipB and SipC (major SPI-1 eﬀectors mediating
invasion) by Western blot analysis on bacterial cell lysates.
A reduction can be seen in the level of these eﬀectors in the induced strain as
compared to wild type strain with empty vector (Fig.2.12). This result is consistent
to invasion phenotype seen in the YshB induced strain.
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Fig. 2.12. YshB induction reduces the expression of invasion
genes: (A)Immunoblot analysis of bacterial whole cell lysates for the
expression of SipA, SipB and SipC after being grown under SPI-1
inducing conditions. Polyclonal rabbit anti-SipA, anti-SipB and antiSipC primary antibodies were used whereas rabbit anti-ICDH was
used to probe the loading control.(B) Quantitative representation of
normalized relative intensity for reduced protein levels.

2.4.5

Translocation rate of eﬀector protein is not aﬀected on YshB induction

Multiple bacterial eﬀectors participate in the internalization of Salmonella into
the non-phagocytic epithelial cells. These eﬀectors are translocated into the host cell
through the Type III secretion system [295].
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Therefore, a change in the translocation eﬃciency could potentially aﬀect the
bacterial invasion. To test the translocation of SipA into HeLa cells in the YshBinduced strain, we conducted the β-lactamase assay. In this, we co-transformed the
SL1344 strain with a plasmid expressing yshB (from a pACYC backbone) and plasmid
pM1644, which has the sipA gene fused to the β-lactamase TEM [304] to infect HeLa
cells. The fusion protein (SipA-TEM) from pM1644 translocates from bacteria to
the host cell through the T3SS, and upon addition of the substrate CCF4, which is
cleaved by the β-lactamase, the color of the host cell changes from green to blue.
As shown in Fig.2.13A and B, the translocation rate of SipA remains unaﬀected
on YshB induction. The SipA level in the cell expressed from plasmid pM1644 also
remained unaﬀected upon YshB induction (Fig.2.13C).

2.4.6

YshB is not a translocated eﬀector

Furthermore, we showed that YshB itself is not a translocated eﬀector by conducting the same translocation assay by using a plasmid construct in which sipA from
pM1644 is replaced with yshB (Fig.2.14).

2.4.7

YshB is required for eﬃcient intracellular Salmonella replication

Once Salmonella successfully invades non-phagocytic cells, it switches its priorities to modulating the intracellular microenvironment which consists primarily of a
modiﬁed phagosome known as the Salmonella-containing vacuole (SCV) to promote
survival and replication [315]. A specialized panel of proteins mediates the maintenance of SCV integrity and thus the intracellular survival.
Since YshB aﬀected the invasion process, we assessed the role of this small protein
in intra-macrophage survival. The data in Fig.2.15 indicates that YshB indeed plays
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Fig. 2.13. Translocation rate of a major SPI-1 protein remains
unaltered upon YshB induction: (A) β-lactamase based translocation assay to assess translocation eﬃciency of SipA from pM1644
in YshB induced cells. Wild type Salmonella with pM1644 and plasmid pZP2277, in which the sipA from pM1644 is replaced by the RfA
cassette of Gateway Vector Conversion System were used as positive
and negative controls respectively. The translocation eﬃciency was
evaluated by enumerating blue vs green cells under a confocal laser
scanning microscope. (B) Percentage of blue cells to quantify the
SipA-TEM translocation eﬃciency. Three independent experiments
were carried out and the mean + SD is represented as error bars. (C)
Immunoblot analysis of the bacterial culture used in Figure 2.12A
to show the SipA expression from pM1644 remains unaﬀected when
YshB is induced.
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Fig. 2.14. YshB is not a translocated eﬀector: A β-lactamase
translocation assay was conducted by using a plasmid construct in
which sipA from pM1644 was replaced with yshB (pyshB-TEM’ ).
Wild type Salmonella with pM1644 and plasmid pZP2277 were used
as positive and negative controls respectively.

a role in the survival of this bacterium inside macrophage cells. This demonstrates
that YshB plays a substantial role in modulating diverse phases of bacterial infection.

2.4.8

yshB expression is induced under the SPI-2 inducing in vitro conditions and when inside macrophage cells

Gene expression is tightly regulated by the immediate environment the pathogen
encounters. Our data indicated that Salmonella might be responding to the environmental changes by regulating yshB expression.
We therefore conducted experiments to assess the expression of yshB from its own
promoter under various environmental conditions. For the in vitro conditions, we
selected diﬀerent growth stages when grown in LB broth, along with growth in 0.3M
NaCl LB broth (invasion inducing media) and SPI-2 media (mimicking intracellular
conditions). We also examined the expression level of yshB when the cells were inside
the macrophage.
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Fig. 2.15.
YshB is required for eﬃcient intracellular
Salmonella replication: Replication fold of ΔyshB Salmonella
strains along with the complemented strain and YshB induced strain
by Gentamicin Protection Assay. Data represents mean of three independent experiments with standard deviation from mean and asterisks
indicate a statistically signiﬁcant diﬀerence with p values indicated.

The results indicate that, yshB expression is considerably high when grown in the
SPI-2 media and even higher when the bacterium is inside macrophage cells (intracellular phase of life cycle) (Fig.2.16). This shows that yshB expression is upregulated
during the distinct physiological phase of intracellular stage of the bacterial life cycle. Hence, this corroborates the observation that YshB plays a signiﬁcant role in
Salmonella intracellular survival.

2.4.9

YshB has signiﬁcant eﬀect on Salmonella mouse virulence

Competitive index assay is frequently used to assess virulence of bacterial
pathogens in mouse model.

For this, we employed mixed infections with wild
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Fig. 2.16. yshB expression is signiﬁcantly higher under
the SPI-2 inducing in vitro conditions and when inside
macrophage cells: Immunoblot analysis to compare the endogenous
yshB expression levels from its native promoter under various in vitro
conditions and inside RAW 264.7 macrophage cells. Relative band intensity was determined by dividing the intensity of YshB-EGFP band
by that of ICDH and normalized to 1 for the LB OD600 of 1 condition. The normalized relative intensity is the average value from two
independent experiments with indicated standard deviation.

type, mutant and the complemented strains to assess attenuation of virulence in
vivo.

This was facilitated by the fact that the ΔyshB strain had a kanamycin

cassette replacing the yshB gene, so that it could be selected on double antibiotics
(Streptomycin/Kanamycin) LB plates, as opposed to the wild type strain which only
had the Streptomycin marker.
Our results demonstrate that YshB is signiﬁcant not only in the in vitro
macrophage model for intracellular survival but also during mouse virulence. The
competitive index for ΔyshB strain was 0.39 for spleen colonization and 0.52 for
liver colonization (Fig 2.17). When the small protein was expressed via a plasmid
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from its native promoter, the virulence phenotype was restored to almost wild type
level in both cases.
This strongly indicated that YshB mediates a signiﬁcant role in Salmonella virulence.

Fig. 2.17. YshB has signiﬁcant eﬀect on Salmonella mouse
virulence: Competitive Index Assay was conducted using mixed bacterial cultures for infection. Mixtures containing wild type and ΔyshB
or wild type and the complemented strain were used to infect BALB/c
mice intraperitoneally. Liver and spleen from the animals were harvested two days post infection to determine the competitive index of
respective strains with respect to the wild type. Asterisks indicate
statistical signiﬁcance with indicated p values.

2.5

Discussion
In this chapter, we have characterized a previously undeﬁned small protein YshB

and established its role in regulating discrete aspects of bacterial pathogenesis.
This work was initiated to assess the roles of Salmonella small RNAs in invading host epithelial cells. Remarkably though, we found that a small protein YshB
encoded through an open reading frame within a small RNA molecule locus was
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able to signiﬁcantly aﬀect the regulation of bacterial pathogenesis. In a similar case,
where a novel small protein was serendipitously found to be encoded within a small
RNA, Wadler and Vanderpool reported that a 43-amino acid small protein SgrT was
encoded within a transcript of a small RNA SgrS [316].
YshB is a 36-amino acid small protein ﬁrst annotated in a screen based on presence
of ribosome binding sites [293], and later validated as a protein expressing gene with a
predicted transmembrane domain in E. coli [294]. This protein is ubiquitously present
in Salmonella species, with 100% sequence identity among the common pathogenic
serovars S. Typhimurium, S. Typhi, S. Enteritidis and S. Choleraesuis. Further,
among the members of Enterobacteriacae, Salmonella YshB sequence is 92% identical
(33 out of 36 amino acids) to the Escherichia coli (strain K12), Shigella and Klebsiella
oxytoca protein. Moreover, prior to this study, this protein has not been described as
having known functions or any roles in bacterial virulence.
Essentially, we describe here that YshB and not the encompassing small RNA
STnc1450 could positively regulate bacterial survival within macrophages and also
virulence in mice. Moreover, we propose that the induction of YshB represents the
intracellular phase, and consequently is suﬃcient to downregulate Salmonella invasion to facilitate intracellular survival and replication. This repression of invasion
machinery resulted in the decrease in the levels of major invasion proteins SipA, SipB
and SipC, and consequently formation of weaker ruﬄes compared to the wild type.
We further characterized YshB as a regulator protein as it did not translocate into
the host cell via the Type III secretion system.
Salmonella encounters various diﬀerent environmental conditions in which the
bacteria have to compete to survive before, during and after the infection. In order
to ensure a successful transition to a new environment, Salmonella regulates the expression of T3SS-1 genes encoded in SPI-1 to the locations where these are needed. A
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complex network of regulators has been identiﬁed that are responsible for controlling
the expressions of these genes. Once the invasion of host cell is complete, Salmonella
downregulates T3SS-1 and initiates SCV biogenesis, for which the T3SS-2 induction
is essential [185].
Many environmental cues are known to regulate gene expression in Salmonella.
One example of this is the repression of SPI-1 genes by bile. This occurs in the
proximal sites of small intestine, where the bacteria do not invade the host cells [317].
Furthermore, the cationic peptides produced inside the macrophages are also known
to silence the expression of SPI-1 genes where invasion is no longer desired [318].
Here, we show yshB expression was increased when grown in a low Mg2+ in vitro
medium, an environment mimicking the intracellular conditions. Moreover, we could
also detect an increase in YshB level when the bacteria were inside the macrophage.
Importantly, we found YshB plays a role in Salmonella intracellular survival, as the
knockout mutant had a defective phenotype.
Not only does the expression of unnecessary genes results in energy expenditure,
but could also be detrimental. In a study to examine the temporal expressions of
invasion genes, Boddicker et al. found that down-regulation of invasion gene expression was partly mediated by Lon protease and this was essential for the intracellular
survival of Salmonella [319]. An uncalled for expression of SPI-1 genes inside the
macrophage results in excessive induction of programmed cell death, and this is controlled by the Lon protease [320]. This was supported by the previous ﬁndings from
Takaya et al. that in a Δlon mutant, the transcription of SPI-1 genes were dramatically enhanced [182, 321]. Consistent to this, we show in our study that conditions
in which YshB expression is induced, such as inside the macrophages, the invasion
eﬃciency is markedly reduced.
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Murine salmonellosis can result in access to the deeper tissues followed by colonization of diverse host niches by the bacteria. After the bacteria invade the intestinal
epithelial cells, they eventually establish themselves in the organs of reticuloendothelial system such as liver and spleen. Virulence contributed by a particular bacterial
factor thus can be assessed also by its eﬃciency to colonize these organs. We show
here that YshB signiﬁcantly aﬀects the ability of bacteria to successfully establish a
niche in organs such as liver and spleen. YshB thus is a positive regulator for the
intracellular phase and Salmonella virulence.
The next chapter of this dissertation explores the molecular bases of YshB mediated regulation.
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3. YSHB MODULATES SALMONELLA
INTRACELLULAR SURVIVAL AND VIRULENCE BY
POSITIVELY REGULATING THE EXPRESSION OF
PHOP AND FADB PROTEINS
3.1

Abstract
The phenotypic consequences of yshB knock out and induction pointed to the

direction of regulation of genes involved in Salmonella intracellular survival and virulence. We therefore examined the eﬀects on the master regulators of survival and
virulence. Moreover, we conducted a global proteomics proﬁle to comprehensively
analyze any variations in the protein levels in the cell upon YshB induction. We
found YshB positively regulates the expression of phoP and fadB genes to account
for the observed phenotype. The eﬀects on these targets however seem to be indirect
as we did not see direct interaction between YshB and these proteins.

3.2

Introduction
The essential role of phoP gene for intracellular survival in macrophages and

mouse virulence was demonstrated in a study in 1989 [193]. This gene along with
phoQ comprises a two-component system and regulates multiple aspects of bacterial
metabolism and virulence [195]. Miller et al. proposed environmental signals such
and starvation would trigger the PhoQ mediated phosphorylation of PhoP, resulting
in the downstream activation of pag (for phoP -activated gene) genes [194].
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Interestingly, the PhoP/PhoQ two-component system also acts as a key genetic
switch to mediate repression of invasion associated genes within macrophage by downregulating the expression of master regulator of invasion, hilA [156, 204]. A ﬁne
tuned balance primarily mediated by the environmental signals to regulate the expression of the operon is therefore critical to sustain the virulent properties of this
bacterium [322].
The chemical environment which the bacteria encounters within the host has a robust inﬂuence in the progress of infection. Notably in the host gastrointestinal tract,
the interaction between the resident population of microbes and the host largely determines the chemical constituents of the immediate neighborhood. Initially believed
to be commensals, these resident ﬂora signiﬁcantly manipulate the surroundings of
their habitat via interactions with the intestinal mucosal surface and epithelium [323].
The fatty acid composition of the micro-environment is one such aspect which depends on the host-microbiome interplay. The direct and indirect detrimental eﬀects of
long chain fatty acids on bacterial growth and survival have been studied extensively.
Therefore, it is likely that the bacteria would employ strategies to protect themselves
from the toxic eﬀects elicited by the surrounding fatty acids molecules. One possibility is the induction of pathways to break down the long chain fatty acids to shorter
lengths. It is known that the long chain fatty acid act as ligands to derepress the
expression of genes mediating fatty acid breakdown. This can be viewed as an adaptation to use these substrates as a signal to prime the bacteria for accomplishing the
eventual breaking down and reducing the toxic eﬀects of the longer chain fatty acids.
Under such scenario, the upregulation of fatty acid degradation pathway would be
favored during the intramacrophage stage. Interestingly, one of the key proteins of
the fatty acid breakdown pathway FadB, was seen to be induced under in vivo conditions [324]. This suggested that induction of fatty acid breakdown may assist the
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bacteria to inhibit and survive the local inﬂammatory response encountered when
they are inside an animal host. This observation also hints at the possibility that
the proteins of the β-oxidation pathway could play important role in intracellular
survival.
In this chapter, we demonstrate that YshB regulates the intracellular and virulent phases by modulating the levels of PhoP and FadB proteins. YshB induction
upregualted the expression of phoP and fadB genes. Interestingly, we further show
here that FadB plays an important role in bacterial intramacrophage survival. Notably, FadB also acts as a negative regulator of bacterial invasion. This is consistent
with the premise that a positive regulator for survival can inhibit the invasion machinery. Hence, we propose that the switch mediated by YshB from invasion competent
to survival competent phase demonstrated in previous chapter is orchestrated largely
via PhoP and FadB proteins.

3.3

Materials and Methods

3.3.1

Plasmids

Induction plasmids were generated as described in Chapter 2, by cloning the
PCR-generated amplicons into vectors pZP1137 or pZP545. The plasmid carrying
fadB point mutation was constructed by QuikChange site-directed mutagenesis kit
(Stratagene) using the Pfu Turbo DNA polymerase (Agilent Technologies, Inc.) following manufacturers instructions.

3.3.2

β-galactosidase assay

The promoter region of the respective genes was cloned into the XmaI/XbaI site
of a promoterless lacZ possessing suicide vector pSB1039. The resulting plasmids
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were then introduced into wild-type Salmonella via conjugation and integrated into
the chromosome by homologous recombination. The resulting strains were subjected
to β-galactosidase assay as previously described [325].

3.3.3

Immunoblotting

For assessing the PhoP-Flag levels, overnight LB culture was washed twice in
sterile PBS and subcultured in the SPI-2 inducing media with a 1:30 dilution for
6 hours. One ml of this culture was centrifuged and the bacterial pellet lysed in
the Laemmli buﬀer and subjected to Western blot. Monoclonal anti-Flag antibody
(Sigma) was used to probe the PhoP protein while polyclonal anti-ICDH antibody
was used to probe the loading control.

3.3.4

Proteomic analysis

Global proteomic analysis of YshB induced strain was carried out in collaboration
with Dr. Ernesto Nakayasu at the Bindley Bioscience Center, Purdue University.
The wild type Salmonella containing an empty vector control and pyshB plasmid
were cultured under SPI-1 inducing conditions to OD600 of 1.0. The cell pellets of
the respective strains were then subjected to protein digestion, labeling with 4-plex
isobaric tags for relative and absolute quantiﬁcation (iTRAQ) reagent and peptide
fractionation by high pH reverse phase liquid chromatography.
Brieﬂy, bacterial cells were lysed with silica beads in 50 mM NH4 HCO3 buﬀer by
vortexing. Cell lysate proteins were then denatured in 8 M urea in 50 mM NH4 HCO3
containing 5 mM dithiothreitol (DTT) for 30 min at 370 C. This was followed by
alkylation of samples with iodoacetamide to a ﬁnal concentration of 10 mM by incubating for 30 min at room temperature in dark. For digesting the samples, the
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reaction was diluted 8-fold with 50 mM NH4 HCO3 and incubated with trypsin at
an enzyme/protein ratio of 1/50 (m/m)for 4 h at 370 C. Samples were desalted with
C18 SPE cartridges as previously described [326]. Peptides derived from cell lysates
were labeled with 4-plex iTRAQ reagent (Applied Biosystems) according to the manufacturers instructions. This was followed by fractionation by high-pH reverse-phase
liquid chromatography as previously described [327]. Peptides were collected ﬁrst into
60 fractions, then concatenated into 15 fractions, and dried in a vacuum centrifuge.
For quantitative proteomic analysis, peptides were dissolved in 0.1% formic acid
and loaded into a C18 trap column connected to a nanoHPLC system (Ekspert
nanoLC 400; Eksigent). The separation was performed in a capillary C18 column.
Eluting peptides were directly analyzed in an electrospray ionization mass spectrometer (5600 TripleTOF; AB Sciex). Full mass spectrometry spectra were collected in
the range of 400 to 2000 m/z, and the top 20 most intense parent ions were submitted
to fragmentation using rolling-collision energy. The identiﬁcation and quantiﬁcation
of peptides were performed with Paragon software as part of the ProteinPilot package
(AB Sciex) by searching tandem mass spectra against Salmonella enterica serovar Typhimurium SL1344 sequences downloaded from Uniprot KnowledgeBase. Database
searches were performed considering trypsin digestion, cysteine residue alkylation
with iodoacetamide, and biological modiﬁcations as factors. Peptides were ﬁltered
with a conﬁdence score above 95. The iTRAQ channel intensities were extracted using ProteinPilot and intensities from diﬀerent peptide-spectrum matches and peptides
from the same protein were summed together. Sample load was then normalized by
total channel intensity and signiﬁcance was tested by analysis of variance (ANOVA)
using InfernoRDN [328].
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3.3.5

Bacterial Two-Hybrid assay

Bacterial two-hybrid assay for screening putative targets of the small protein was
carried out using the BACTH-system [329, 330].
yshB was cloned into pEB1029 (KanR ) [330] so that it was translationally fused
to the T25 fragment of Bordetella pertussis cya gene to get plasmid pEB1029-yshB
(pZP3649). This plasmid was transformed to cya deﬁcient E. coli strain BTH101
[329]. pEB1029 has a Flag epitope enabling detection of the recombinant proteins.
Genomic DNA from S. Typhimurium SL1344 was extracted and partially digested
with Sau3AI. Fragments corresponding to 500bp to 3kb was puriﬁed and ligated
into BamHI digested pUT18C (AmpR ), the plasmid with T18 fragment of cya gene.
This was transformed to DH5α, and the colonies pooled to assemble the library.
Plasmid was extracted from the library and transformed into BTH101 with pEB1029yshB. This was plated onto double antibiotics LB plates with 40µg/ml X-Gal or M63
medium with 1% lactose as sole carbon source.
For detecting interaction of YshB with individual targets, each putative target
was cloned into pEB1029 and pEB1030 [330]. This was then co-transformed with
pEB1029-yshB or pEB1030-yshB into BTH101 strain and plated onto LB plates with
40µg/ml X-Gal or M63 medium with 1% lactose as sole carbon source. Interaction
between the two proteins would reconstitute adenylate cyclase in the BTH101 strain
which could be visualized as a Lac+ phenotype [331].

3.4

Results

3.4.1

YshB positively regulates PhoP level in Salmonella

Since YshB was found to be important in successfully establishing the intracellular lifestyle and also virulence in mice, we checked if this small protein aﬀects the
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expression of the phoP/phoQ operon. We constructed the transcriptional (lacZ ) fusion to the operon and a translational (Flag-tagged) fusion to the PhoP protein in the
chromosome in wild type SL1344 as well as ΔyshB background. We then monitored
the role of YshB on expression of phoP/phoQ operon and PhoP protein level in these
constructs. We found that upon exogenous expression of yshB, the transcription activation of the phoP-phoQ operon increased by around 2 fold, as determined by a
β-galactosidase assay (Fig.3.1A). Moreover, in the ΔyshB strain, the transcription
activity was lower compared to the wild type strain.
This also translated with the observation that the PhoP level was increased in the
YshB induced cells by around 2 fold (Fig.3.1B), whereas the level was relatively low in
the ΔyshB background. Since the PhoP/PhoQ two-component system is essential for
survival in macrophage as well as known to mediate SPI-1 repression, we propose that
the phenotype associated with YshB is mediated partly via this signaling pathway.

3.4.2

YshB does not aﬀect the regulation of the ssrAB operon

The SsrA/SsrB two component system is a major regulator of SPI-2 gene expression. We next checked if YshB regulates the expression of these by using transcriptional and translational fusion constructs of these genes.
The results in Fig.3.2 indicate that YshB induction does not signiﬁcantly aﬀect
the transcription or translation of the ssrAB operon.

3.4.3

YshB induction causes upregulation of proteins involved in fatty
acid oxidation pathway

In order to compare the global protein proﬁle between the wild type and YshB
induced strains, a comprehensive quantitative proteomic analysis using isobaric tags
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Fig. 3.1. YshB positively regulates PhoP level in Salmonella:
(A) β-galactosidase assay to demonstrate that YshB induction upregulates the transcription of the phoPQ operon, whereas in the ΔyshB
strain, the transcription activity is lower. The transcriptional lacZ
fusion strains were subjected to β-galactosidase assay, and the readouts expressed as Miller units. Three independent experiments were
carried out and the mean + SD is represented as error bars. Asterisks
indicate a statistically signiﬁcant diﬀerence with indicated p values.
(B) Immunoblot analysis showing increase in the PhoP level upon
YshB induction and reduced PhoP level in ΔyshB strain. Relative
band intensity was determined by dividing the intensity of PhoP band
by that of ICDH and normalized to 1 for the strain with empty vector. The normalized relative intensity is the average value from three
independent experiments with indicated standard deviation.
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Fig. 3.2. YshB does not aﬀect the regulation of the ssrAB
operon: (A) β-galactosidase assay was carried out which showed
that YshB induction does not signiﬁcantly alter the transcription of
the ssrAB operon. Three independent experiments were carried out
and the mean + SD is represented as error bars. (ns: not signiﬁcant). (B) Immunoblot analysis showing levels of SsrB protein upon
YshB induction. Relative band intensity was determined by dividing
the intensity of SsrB band by that of ICDH and normalized to 1 for
the strain with empty vector. The normalized relative intensity is
the average value from three independent experiments with indicated
standard deviation.
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for relative and absolute quantiﬁcation (iTRAQ) method was carried out [332, 333].
Brieﬂy, the SL1344 wild type strain with empty vector (WT pVector) and the one
expressing YshB from an arabinose inducible plasmid (WT pyshB ) were sub-cultured
from overnight LB culture in SPI1 inducing condition and the presence of 1mM ﬁnal
concentration of L-arabinose, till OD600 reached 1.0. The bacterial cells were spun
to separate supernatant fraction and cell pellet. Cell lysates were then subjected
to iTRAQ labeling and data analysed to generate a quantitative proﬁle of protein
expression level. The level of a number of proteins were found to alter in the YshB
induced strain (Table C.1). Interestingly, this data led us to investigate a link between
YshB induction and fatty acid oxidation pathway. The levels of key proteins of the
pathway, namely FadA and FadB were found to increase signiﬁcantly in the YshB
induced strain (Fig.3.3).
Among these, FadB was selected for further analysis based on its role we witnessed
in Salmonella virulence.

3.4.4

YshB positively regulates FadB expression in a FadR dependent
manner

In order to validate the eﬀect of YshB induction on FadB level, we ﬁrst constructed strains with a Flag encoding tail on the fadB chromosomal locus of the wild
type, ΔyshB, ΔfadR and ΔyshB ΔfadR backgrounds [302]. We also constructed the
transcriptional (lacZ ) fusion to the fadBA operon in both wild type and ΔyshB background. We then examined the eﬀects of yshB knockout and YshB induction on these
backgrounds to assess how it aﬀected the transcription of the operon and the protein
level of FadB in the cell by conducting β-galactosidase and Western blot analysis.
From Fig.3.4A, it is evident that upon yshB knockout, the transcription activity
of the fadBA operon is reduced while it is higher upon YshB induction. Similarly,
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Fig. 3.3. YshB induction causes upregulation of proteins involved in fatty acid oxidation pathway: : (A) Average fold
change of FadA and FadB proteins on YshB induction as determined
by quantitative proteomic analysis (iTRAQ). (B) Genomic orientation
of fadBA operon in Salmonella chromosome.

FadB level decreases in the cell in the ΔyshB strain, while it increases upon induction
of YshB (left panel) and this is dependent on the presence of FadR regulator, since
YshB fails to do so in a ΔfadR background (Fig.3.4B).
This told us that YshB is a positive regulator of the fadBA operon.

3.4.5

FadB induction causes signiﬁcant decline in invasion rate

Since we validated that FadB levels are increased upon YshB induced, we hypothesized that FadB would mimic the phenotype displayed by YshB.
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Fig. 3.4. YshB positively regulates FadB level in Salmonella:
(A) β-galactosidase assay to demonstrate that YshB positively regulates the transcription of the fadBA operon. The transcriptional
fusion strains were subjected to β-galactosidase assay, and the readouts expressed as Miller units. Three independent experiments were
carried out and the mean + SD is represented as error bars. Asterisks
indicate a statistically signiﬁcant diﬀerence with indicated p values.
(B) Immunoblot analysis showing increase in the FadB level upon
YshB induction and reduced FadB level in ΔyshB strain.
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FadB encodes a fatty acid oxidation complex subunit which converts enoyl-CoA to
3-ketoacyl-CoA. In the same operon is a gene encoding FadA which catalyses the last
step of the pathway resulting in shortening of the input acyl-CoA by two carbon atoms
to give acetyl-CoA [245]. The His450 is the catalytic residue for the dehydrogenase
activity of FadB [334].
We analyzed the eﬀects of exogenously expressing wild type and the catalytically
inactive FadBH450Q protein for the dehydrogenase activity in Salmonella and assessed
the invasion rate. To our surprise, we found the invasion phenotype seen upn FadB
induction was independent of its dehydrogenase activity (Fig.3.5).

Fig. 3.5. FadB induction causes signiﬁcant decline in invasion
rate: Gentamicin protection assay was conducted to assess the invasion eﬃciency upon FadB induction. It is notable that the phenotype
is independent of the dehydrogenase activity of FadB.
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Furthermore, this phenotype was also seen in the ΔfadL background (Fig.3.6B),
where FadL is a membrane protein responsible for transporting external long chain
fatty acids (LCFAs) into the periplasm [245].
This suggested that FadB accumulation in the cell may be suﬃcient to act as a
signal, independent of its enzymatic activity or the presence of its substrates in the
vicinity. The scenario we thus propose is upon induction of YshB, there is an increase
in FadB level in the cell, which mimics the intracellular phase of the bacterial life cycle
and therefore a switch to the toned-down invasion machinery.

3.4.6

fadB deletion compromises intracellular survival

FadB was implicated to be one of the in vivo induced (ivi) genes when mice
were challenged with wild type Salmonella strain [324]. It was proposed that FadB
would contribute to in vivo survival, since the FadB-mediated fatty acid degradation
would possibly reduce the multiple potential adverse eﬀects of high concentration of
fatty acids. This led us to hypothesize that FadB would also be important for the
intracellular survival of Salmonella within macrophage cells. Consequently, FadB
induction would mimic the intracellular phase of bacterial life cycle, hence repressing
the invasion machinery.
To test this, we conducted gentamicin protection assay for intracellular survival of
fadB knockout mutant. Brieﬂy, RAW 264.7 cells were infected (MOI: 10) by respective Salmonella strains followed by lysis and plating 2 and 24 hours post infection.
The fold replication was determined by colony counts on plates after each time point.
From the survival assay, it was evident that FadB plays a role in the intracellular
phase of bacterial life cycle (Fig.3.7). Similar to what we detected in the invasion
phenotype, even the FadBH450Q protein which is defective in its dehydrogenase ac-
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Fig. 3.6. FadB invasion phenotype is independent of presence
of its long chain fatty acid substrates: (A) Deletion of fadL, the
transporter of long chain fatty acid has no signiﬁcant eﬀect on the
invasion eﬃciency of Salmonella (B) Inducing FadB in ΔfadL strain
causes reduced invasion eﬃciency.
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tivity was able to rescue the phenotype. This supported our proposition that FadB
molecules could act as signals to trigger a switch to intracellular mode of life.

Fig. 3.7. FadB plays a role in Salmonella intracellular survival: Gentamicin protection assay was carried out to assess the survival eﬃciency of ΔfadB strain. Plasmids expressing the wild type
FadB and FadBH450Q proteins were used to complement the phenotype. Asterisks indicate statistical signiﬁcant diﬀerence with p value
indicated.

Surprisingly, the role of FadA protein in the bacterial virulence could not be established, as neither the ΔfadA nor the FadA induced strain displayed any signiﬁcant
phenotype in the survival or the invasion assay Fig.3.8. This is peculiar since both
FadB and FadA are expressed through the same operon.

3.4.7

PhoP and FadB may not be the only targets of YshB

In order to assess if PhoP and FadB are the only targets of YshB, the eﬀects of
YshB induction in the ΔphoP, ΔfadB and a double knock out ΔphoP ΔfadB backgrounds on invasion rate were assessed. From the result in Fig.3.9, it can be seen that
inducing YshB in the ΔphoP or the ΔfadB does reduce the invasion rate, however
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Fig. 3.8. FadA has no signiﬁcant role in Salmonella virulence:
Eﬀects of FadA induction on invasion eﬃciency (A) and fadA knockout deletion in intracellular survival (B) were assessed by gentamicin
protection assay. (ns: not signiﬁcant)

not to an extent that it does in a wild type background. Interestingly, deleting both
phoP and fadB didn’t show any additive eﬀect on the invasion phenotype mediated
by YshB. This suggested that YshB may be modulating bacterial invasion through
other targets as well.
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Fig. 3.9. PhoP and FadB may not be the only targets of YshB:
Relative invasion rates were assessed by Gentamicin Protection Assay. Invasion eﬃciency of wild type strain with an empty vector was
normalized as 100. The data are the averages of three independent experiments with error bars indicating standard deviations from mean.
Asterisks indicate a statistically signiﬁcant diﬀerence compared to the
empty vector using the Students t-test with p value indicated.

3.4.8

FadR plays a signiﬁcant role in Salmonella virulence

One of the key proteins of the fatty acid metabolism is FadR, the negative regulator of fatty acid degradation pathway. Since we demonstrated that FadB plays a
signiﬁcant role in the invasion and intracellular survival of Salmonella, we therefore
constructed a ΔfadR strain which should have an increased FadB level in the cell,
and evaluated the invasion and survival phenotype of this strain Fig.3.10A and B.
The results were in accordance with our previous data, as ΔfadR strain had a significantly reduced invasion and enhanced survival phenotype. Moreover, we were able
to show that upon fadR deletion or FadB induction, the protein level of the major
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SPI-1 eﬀectors was considerably reduced, thus accounting for the reduced invasion
phenotype (Fig.3.10C and D).

Fig. 3.10. FadR plays a signiﬁcant role in Salmonella virulence: (A) Gentamicin protection assay for invasion with a fadR
knock-out mutant along with a complemented strain. (B) Gentamicin protection assay for intracellular survival with a fadR knock-out
mutant strain. Asterisks indicate a statistically signiﬁcant diﬀerence.
(C) Immunoblot analysis to check the protein levels of SipA, SipB
and SipC proteins in a ΔfadR strain along with the FadB induced
strain.(D) Quantitative representation of normalized relative intensity for reduced protein levels.
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3.4.9

YshB does not interact with PhoP, PhoQ, FadB or FadR

Small proteins preferably act by directly interacting with their targets. We therefore checked whether or not YshB interacts with its putative targets using the bacterial two-hybrid system [329, 330].
Brieﬂy, the putative interacting proteins were translationally fused to either the
T25 or the T18 fragments which constitute the catalytic domain of Bordetella pertussis
adenylate cyclase. In case of an interaction between the two hybrid proteins, there is
a functional complementation between T25 and T18 fragments which leads to cAMP
synthesis. The generation of cyclic AMP then triggers the transcriptional activation
of operons that yield a characteristic phenotype, in this case, the β-galactosidase
activity. However, using this system, we were unable to detect any interaction between
YshB and its putative target proteins (Fig.3.11).

Fig. 3.11. YshB does not interact with PhoP, PhoQ, FadB or
FadR: A bacterial two hybrid assay was conducted to examine any
interaction between YshB with PhoP, PhoQ, FadB or FadR proteins
using BACTH system. Miller Units was used as the read out following
β-galactosidase assay.
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3.4.10

PhoP and FadB act independently in mediating virulence phenotype

Since FadB was shown to be involved in intracellular survival and repressed bacterial invasion, we tested if this protein regulates or is regulated by PhoP. For this,
we exogenously expressed FadB in the cell to measure the level of PhoP. Similarly,
we assessed the eﬀects of PhoP induction on FadB levels in the cell. From Fig.3.12,
it is evident that inducing either PhoP or FadB in the cell would not signiﬁcantly
alter the level of FadB or PhoP respectively. Therefore, it is more likely that these
two proteins mediate similar function in the cell independently.

Fig. 3.12. PhoP and FadB act independently in mediating virulence phenotype: (A) Immunoblot analysis to examine the eﬀects
of inducing FadB on the level of PhoP in Salmonella (B) Immunoblot
analysis to examine the eﬀects of inducing PhoP on the level of FadB
in wild type and fadR knock-out Salmonella.

76
Based on the cumulative results assembled in this study, we propose a working
model as outlined in Fig.3.13. In this, the small protein YshB is shown to modulate
the invasion and replication phases by positively regulating the expression of PhoP
and FadB proteins.

Fig. 3.13. A working model - YshB facilitates the switching from invasion to subsequent intracellular survival of
Salmonella: YshB modulates the discrete virulence phases of
Salmonella by positively regulating PhoP and FadB levels in the cell.
PhoP is a known activator of the SPI-2 system necessary for intracellular survival and virulence. Furthermore, PhoP is known to repress
the SPI-1 system essential for invasion of host cell. Here we also show
that FadB, whose level increases upon YshB induction, is also able
to repress the invasion machinery. FadR is the negative regulator for
fadB expression, whereas presence of long chain fatty acids increases
FadB level in the cell. Presumably, PhoP and FadB are likely not the
sole targets of YshB mediated regulation of Salmonella pathogenesis
and other molecule(s) (denoted as “?”) may well be involved. Arrowhead indicates activation while bar-head indicates inhibition. Dotted
lines indicate probable signaling pathway.
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3.5

Discussion
In this chapter, we show the phenotypes displayed on yshB knockout or YshB

induction are mediated largely via two downstream proteins PhoP and FadB.
The SPI-2 system has been known to regulate the expression of SPI-1 genes involved in bacterial invasion [335]. Particularly, the PhoP/PhoQ two component system needs to remain down-regulated for the induction of SPI-1 genes to promote
bacterial invasion [336]. PhoP is the response regulator and is known to repress the
SPI1 genes, while activating the expression of pag genes. This diﬀerential regulation
corresponds to the spatial localization of the bacteria in the macrophages where pag
genes are needed to be expressed as opposed to being in the intestine, where most
SPI-1 genes are expressed [205]. In the case of PhoP, a seemingly narrow cation concentration range is responsible for the activation of most pag genes, with an optimal
expression at a concentration of less than 100µM while at or above 2mM concentration, the expression is completely turned oﬀ [199]. This corresponds well with the
respective sites in the host, where the cation concentrations are relatively higher in the
intestinal environment compared to when the bacteria is inside the phagosome [337].
In our study, we found that inducing YshB increases PhoP level in the cell, and thus
we propose that this could be one of the factors mediating the corresponding virulence
phenotype. Our study adds another layer of regulation upstream of PhoP-PhoQ to
regulate the transition from the extracellular phase to that inside the host cells.
The fatty acid composition present in the intestinal tract may vary depending on
the diet, host metabolism and microbiota of diﬀerent regions of the tract [338]. In this
regard, the role of short chain fatty acids in acting as environmental cues has been
reported previously. Essentially, they can function as signals on where the bacteria
are in the intestinal tract, hence modulate the regulation of virulence, especially the
SPI-1 gene expression in diﬀerent ways [339]. Therefore, while acetate and formate are
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known to activate the SPI-1 genes [340,341]; propionate and butyrate act by repressing
the SPI-1 system [342, 343]. This discrepancy amounts to the fact that diverse fatty
acids are abundant at diﬀerent sites in the intestinal tract and accordingly play a
role in either activating or repressing the SPI-1 system. For instance, propionate and
butyrate are abundant in the large intestinal regions, which are not optimal sites for
inducing bacterial invasion. Hence, these molecules facilitate the down-regulation of
the SPI-1 gene expression. Propionate does this by interfering with HilD activity by
destabilizing this regulator of bacterial invasion [343]. On the other hand, acetate
and formate act as inducers of invasion since their concentration is higher in the
distal ileum [344]. The activation of SPI-1 gene expression by these fatty acids is
mediated via the BarA/SirA two component system which eventually upregulates
hilD expression [340].
Interestingly, not only SCFAs but LCFAs have also been recently reported to
directly modulate the invasion phenotype by binding to HilD and aﬀecting its DNA
binding ability. In this work, they showed that LCFAs acted as direct signals to
regulate a virulence phenotype [345].
In our study, the proteomics data and subsequent immunoblot showed that induction of YshB in Salmonella led to the increased level of FadB in the cell. Moreover, we showed that inducing FadB leads to reduced invasion eﬃciency. FadB is a
hydroxyacyl-coA dehydrogenase that catalyzes the break-down of fatty acids during
β-oxidation [346]. This is a multifunctional protein with the His450 as the catalytic
residue for the dehydrogenase activity [334]. Interestingly, this protein was shown to
be one of the in vivo induced (ivi) genes in Salmonella infected mice [324].
Fatty acids have a profound inﬂuence on macrophage function [347]. In particular, unsaturated fatty acids have been shown to enhance the antibacterial activity
of macrophages [348, 349]. For instance, one of the poly-unsaturated fatty acids
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produced during infection, arachidonic acid has proinﬂammatory metabolites [350].
Moreover, most fatty acids have a detergent-like property which is toxic to bacteria [351]. Therefore induction of fadB inside a phagocyte should prompt the bacteria
to break down the long chain fatty acids (LCFAs), and might assist in suppressing
these adverse eﬀects.
Transcription of fadB is tightly regulated by the repressor of fatty acid oxidation,
FadR. Interestingly, Golubeva et al. in 2016 reported that a ΔfadR strain had a
repressed SPI-1 gene expression [345]. In our work, we also show that the protein
levels of the invasion proteins are reduced in the ΔfadR as well as the FadB induced
strain (Fig.3.10). Since FadR is the negative regulator of fadB transcription, a ΔfadR
strain will have increased FadB levels. Furthermore, they showed that this phenotype
is independent of the presence of free LCFAs as this was not suppressed in a ΔfadL
strain. FadL is a membrane protein responsible for transporting external LCFAs into
the periplasm. Similar to this ﬁnding, we demonstrated in our study that inducing
FadB even in the ΔfadL strain will result in the reduced invasion phenotype. This
suggested that FadB mediated downregulation of SPI-1 system is independent of the
immediate presence of the LCFA substrates in the cytosol. This is further supported
by our data showing a catalytically dead FadBH450Q is still able to demonstrate the
invasion phenotype. This indicates that the enzymatic activity of FadB per se is
not necessary for the induction associated phenotype. We hence propose that FadB
accumulation in the cell is suﬃcient to act as a signal mimicking the induction of
SPI-2 system and consequently triggering the repression of the SPI-1 genes.
Small proteins mediate a variety of functions in bacteria and owing to their small
size, these proteins more commonly act in mechanical ways via direct interaction with
their targets [271]. We attempted to identify Salmonella proteins that interact with
YshB using a bacterial two hybrid screening, but did not ﬁnd any direct targets.
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Although we cannot rule out the possibility that the potential target of YshB could
have been missed in the process. Alternatively, the target for this small protein might
be a small RNA where it may function as a chaperone. Hence, further analysis on
the molecular mechanism of how YshB modulates bacterial virulence is necessitated.
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4. CONSTRUCTION OF GENOME-WIDE SALMONELLA
TYPHIMURIUM SL1344 MUTANT LIBRARY USING
RANDOMLY BAR-CODED TRANSPOSONS
4.1

Abstract
Functional characterization of a gene is commonly assessed by identifying a mutant

phenotype, which can be achieved by either forward or reverse genetics. Even though
several of the environmental stresses that Salmonella encounters during the course of
infection is known, the information on the genetics behind the successful establishment of an infection is still incomplete. Considering the impracticality of analyzing
innumerable mutants with targeted single gene deletions, most study engage in investigating a pool of mutants. Signature Tagged Mutagenesis (STM) provides a means
to diﬀerentiate between diﬀerent mutants. Hence, we planned to utilize the powerful
tool of Random Bar-code Transposon-site Sequencing (RB-TnSeq) to characterize
the hitherto unknown bacterial virulence factors which might play signiﬁcant roles in
the infection process. With this goal, we constructed a comprehensive transposonbased genome-wide Salmonella Typhimurium SL1344 mutant library covering 90%
of non-essential genes.

4.2

Introduction
Identiﬁcation of an uncharacterized gene responsible for a phenotype can be ac-

complished by performing a genetic screening [352]. For the purpose of conducting
such screening by constructing a pool of diverse mutants, transposon mutagenesis
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has been a very reliable tool for decades. In this, a vector system delivers a transposon cassette to a recipient strain so that there are random insertions within the
genome, whereby complete loss of gene function can be achieved on appropriate insertion [353]. However, one caveat with the earlier versions of this tool was inability to
identify particular mutants bearing a phenotype of interest from a pool of thousands
of mutagenized bacteria. Therefore, any functional screening to assess ﬁtness of a
particular mutant in a pooled population was profoundly facilitated by the introduction of signature DNA tags, in a system called Signature Tagged Mutagenesis [354].
The transposons responsible for mutagenesis carry these unique DNA tags, which can
later be detected by downstream high throughput sequencing assays from the pool,
each containing a unique sequence as the tag [355]. These tags can thus be considered
as a molecular barcode which imparts a unique identiﬁcation to each mutant in the
pool. STM thus utilizes the potential of insertional mutagenesis and in vivo negative
selection to screen for a desired phenotype from a population of mutants [356]. Ideally, the desired pool of mutants should have maximal coverage of the genome with
minimal complexity [357].
Discrete virulence factors are involved in growth and survival of bacterial
pathogens under diﬀerent stages of infection. To characterize their roles, a functional
screen on a genomic level can be conducted by employing comprehensive mutant
libraries and next-generation sequencing. The rationale behind this would be to
identify factors, the loss of which results in altered ﬁtness of the bacterium under
a particular condition or when subjected to infection of mammalian cell lines or
animal models. In each case the tags ampliﬁed from genomic DNA isolated from
the input and the output pool can be compared to assign the ﬁtness proﬁles for the
mutagenized strains.
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4.3

Materials and Methods

4.3.1

Bacterial strains, plasmid library and media

Salmonella Typhimurium strain SL1344 was used as the recipient strain for transposon mutagenesis. The vector library used was strain APA766 [358]. This library
consists of the randomly barcoded pKMW7 vector library in E. coli WM3064. The
pKMW7 is a Tn5 class transposon vector that confers resistance to kanamycin and is
DNA barcoded with a 20mer nucleotide. The WM3064 cells are derivative strains of
β2155, which are auxotrophic for Diaminopimelic acid (DAP) [359]. The ﬁnal concentration of DAP was maintained at 300µM in the media. Kanamycin was used at
50µg/ml ﬁnal concentration.

4.3.2

Conjugation

The recipient Salmonella SL1344 strain was grown in LB, whereas the donor
APA766 cells were grown in LB+Kan+DAP until late log phase. The donor culture
was washed twice by centrifuging for 5 minutes at 5000 x g to get rid of the antibiotic. Equal amounts (as determined by OD600 ) of the recipient S. Typhimurium and
donor APA766 cells were mixed together. The mixture was centrifuged to remove the
supernatant, and resuspended in 100µl LB with DAP and conjugated on LB-agar supplemented with DAP. After 10 h of conjugation at 370 C, the cells were resuspended in
LB-broth and plated onto freshly made LB-agar plates containing 50µg/ml kanamycin
(without DAP). Following growth overnight, the kanamycin-resistant colonies were
scraped together into LB-broth with 50µg/ml kanamycin. This pool of mutant library
was then diluted to an OD600 of 0.25 in 100 ml of LB-broth with 50µg/ml kanamycin,
and outgrown at 370 C to a ﬁnal OD600 of 1.5.
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4.3.3

DNA Extraction and Tn-Seq

A 1ml aliquot from the mutant pool was subjected to genomic DNA extraction
with the DNeasy kit (Qiagen). The extracted DNA was sent to the Lawrence Berkeley
National Lab for Tn-Seq. To the remaining volume, glycerol was added to a ﬁnal
concentration of 10% (v/v), and multiple 1ml aliquots were made in cryovials to
prepare -800 C stocks.

4.4

Results
We constructed a randomly bar-coded genome-wide transposon mutant library

in Salmonella enterica serovar Typhimurium SL1344 by conjugating the wild type
SL1344 strain with a pool of donor Escherichia coli strain carrying the Tn5 vector
library (Fig.4.1) [358].
Following the TnSeq, a comprehensive proﬁle of our genome-wide mutant library
was generated, the information for which can be obtained from the following link:
http : //morgannprice.org/tmp/F EBA/Salmon1 M L1 barseqtest/
The summary and coverage of the mutant library is expressed in the following
table:
Table 4.1.
Summary of S. Typhimurium SL1344 randomly barcoded transposon
mutant library
Category
Mutant library name
Transposon used
Method of delivery
Number of strains with unique barcodes
Total number of protein coding genes in the genome
Number of genes with insertions

Name
SL1344 APA766
Tn5
Conjugation
74971
4929
4228
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Fig. 4.1. Scheme for random in vivo transposition to generate
pools of tagged mutants: A complex pool of tagged transposons
is generated and used to mutagenize bacteria of interest, which are
assembled into a pooled library. Diﬀerent colored segments represent
unique DNA tags. (Modiﬁed with permission from [360])

We therefore constructed a comprehensive genome-wide mutant library consisting
of a pool of mutants with unique random insertions in more than 90% of non-essential
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open reading frames of Salmonella genome. DNA can be extracted from this pool
before and after a selective process and sequenced to identify unique tags linked to
each mutation. The sequence information generated from pre- and post-selection
conditions can be compared to distinguish the strains with altered ﬁtness. This
library can thus be used to carry out myriads of experiments by tracking thousands
of unique strains in parallel with an objective to characterize the role of proteins or
small RNA entities with as of yet unknown function.

4.5

Discussion
STM is a robust and powerful screening technique to analyze non-essential genes

and their roles in various aspects of an organism’s life cycle. A critical advantage of
any STM strategy is that each individual mutant carries a unique signature sequence
which helps to ﬁgure out their relative abundance in the pool. Moreover, these
individual mutants are derived from an isogenic background.
However there are some limitations of working with a randomly mutagenized
library. Essentially, a very large number of unique insertions are required to make sure
a maximal coverage of genes of interest. This very high complexity due to the presence
of thousands of insertion mutants creates a “biological bottleneck”, particularly when
using animal models of infection. For instance, during an infection, there are several
stages such as invasion of intestinal epithelial cells or entry into phagocytic cells,
where several mutants of the pool can be stochastically lost rather than due to a true
defect. This will result in the identiﬁcation of signiﬁcant number of false negatives.
There is also a probability of a truly defective mutant being complemented by other
mutants of the pool leading to identiﬁcation of false positives. Another disadvantage
is the insertion is more likely to cause polar eﬀects in the neighboring genes, which
makes the validation of phenotype tricky.
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Despite having these few limitations, the STM strategy has been successfully employed to identify multiple novel virulence factors in a large number of pathogens [361].
Entirely diﬀerent sets of virulence factors can be involved at discrete stages of infection, which necessitates the need of diﬀerent models of infection, preferably infecting
diﬀerent host species with the same library. Furthermore, since no single strategy
could be comprehensive enough by itself, multiple approaches could be adapted that
complement each other to get a broad understanding of virulence determinants of any
pathogen.
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5. CONCLUSIONS AND FUTURE DIRECTIONS
5.1

Research Summary
Salmonella gastroenteritis is one of the most common causes of food-borne disease,

possibly aﬀecting millions of people globally each year.
Here we characterized the role of a novel small protein YshB in mediating a spatiotemporal switch between discrete virulence phases of this bacterium. Small proteins
of less than 50 amino acids are very diﬃcult to identify and characterize, even when
they have many important functions in diverse cellular processes.
In this dissertation, we revealed the functional role of YshB as a positive regulator
for bacterial intracellular survival and virulence. Deletion of yshB gene in wild type
Salmonella resulted in defective intracellular replication and mouse virulence. YshB
was shown to be induced in Salmonella under physiological conditions mimicking intracellular stages, such as in vitro growth media containing low Mg2+ concentrations
(SPI-2 inducing) or inside RAW264.7 macrophage cells. Moreover, we displayed YshB
induction could repress the invasion machinery, as its exogenous expression in the cell
caused signiﬁcant defect in the bacteria’s ability to enter non-phagocytic epithelial
cells. YshB therefore acts as a positive regulator of intracellular survival and negative
regulator of bacterial invasion. It is well known that in Salmonella, a switch from
infective stage to the intracellular stage is accompanied by repression of the mechanisms facilitating invasion. This saves the bacteria from excess energy expenditure
and also protects from triggering of multiple detrimental downstream events, such as
induction of host cell death and activation of host innate immune responses.
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Further, we demonstrated that this regulation by YshB is largely mediated via
two downstream proteins PhoP and FadB, presumably acting independently of each
other. The role of PhoP in Salmonella pathogenesis is well established. Essentially, a
ﬁne-tuned regulation of the phoPQ operon is critical to the maintenance of bacterial
physiology and virulence, as this operon is known to regulate a multitude of functions.
FadB is a key enzyme in the β-oxidation pathway which facilitates the break down of
long chain fatty acids into shorter ones. This act could prove to be crucial in escaping
from the adverse eﬀects which the long chain fatty acids owing to their detergent-like
properties can have on bacterial survival. In addition to playing a role in intracellular
survival, FadB had an inhibitory eﬀect on SPI-1 gene expression. Interestingly, we
found that this property of FadB was independent of its catalytic activity or the
presence of long chain fatty acid substrates. This led us to propose that aggregation
of FadB molecules in the cell was suﬃcient to initiate the down regulation of invasion
genes. Presumably this accumulation acts as a signal mimicking intracellular phase
which triggers the downstream events to subsequently repress the invasion related
genes.
Hence, we provide evidence to a hitherto unknown cross talk between the two
critical phases of the pathogens life cycle mediated by a small protein. We thus
consider YshB as a key molecular liaison in the overall picture of Salmonella virulence. This elucidation adds another layer in our understanding of how this bacterium
orchestrates the transformation once it is inside the host cell.
Understanding the dynamics associated with the coordinated regulation of virulence is fundamental in developing therapeutic strategies. This eventually can lead
to paving ways for controlling the severity of the infection and hence contribute in
reducing the burden of the Salmonella associated ailments among the aﬀected public
domains.
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5.2

Future Directions
In this work, we showed PhoP and FadB as targets of YshB, however we could not

detect any interaction between YshB and these proteins with the BACTH Bacterial
Two Hybrid system. This suggests that these targets may be indirect. Furthermore,
the data indicated that YshB could have pleiotropic eﬀects and may modulate the
regulation of other targets along with these two proteins. In our study, a screening
method based on the same two hybrid system was unable to ﬁnd any potential targets
which interacted with YshB. One possible scenario for this could be the target for
YshB could have been missed during the screening process. For addressing this issue, a
co-immunoprecipitation can be carried out to capture the target. Another possibility
is that YshB could be an RNA binding protein and the target could be an RNA
molecule instead of a protein. For the purpose of identifying any putative RNA
target, RNA capturing technique such as RNA immunoprecipitation can be carried
out.
The role of fatty acid degrading enzymes in mediating bacterial virulence is quite
uncommon. Here we showed that FadB and its regulator FadR play a role in bacterial
intracellular survival and also invasion of host cells. Interestingly, FadB and not FadA
was seen to have a role in virulence. Moreover, it seemed the enzymatic activity of
FadB is not the reason for the associated phenotype. However, FadR is a global
regulator of fatty acid degradation and biosynthesis, and considering its signiﬁcance
in Salmonella virulence, one interesting avenue of research could be to compare the
lipid proﬁles of the wild type with the mutants of these proteins or the overexpressed
strains.
The proteomics study generated a list of proteins whose levels were signiﬁcantly
changed upon YshB induction. These proteins are mostly associated with various
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metabolic pathways. Nevertheless, it would be interesting to test whether these proteins could aﬀect Salmonella virulence.
Small proteins most commonly interact with their targets via direct binding. Even
though small proteins are not known to bind to DNA because of the lack of distinct
protein domains, there is always a possibility. Assays can be performed such as
electrophoretic mobility shift assay (EMSA) with puriﬁed YshB using the regulatory
DNA regions of putative targets to examine any potential interaction.
Since YshB is only 36 amino acids long, we could also mutagenize each relevant
amino acids and examine the eﬀects on protein stability and subsequently the phenotype associated with this protein.
These studies could provide further insights and help understand the molecular
details and functional characterization of YshB.
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[203] E. G. Véscovi, Y. M. Ayala, E. Di Cera, and E. A. Groisman, “Characterization
of the bacterial sensor protein PhoQ– Evidence for distinct binding sites for
Mg2+ and Ca2+ ,” Journal of Biological Chemistry, vol. 272, no. 3, pp. 1440–
1443, 1997.
[204] I. Behlau and S. I. Miller, “A PhoP-repressed gene promotes Salmonella typhimurium invasion of epithelial cells.” Journal of Bacteriology, vol. 175, no. 14,
pp. 4475–4484, 1993.
[205] D. A. Pegues, M. J. Hantman, I. Behlau, and S. I. Miller, “PhoP/PhoQ transcriptional repression of Salmonella typhimurium invasion genes: evidence for
a role in protein secretion,” Molecular Microbiology, vol. 17, no. 1, pp. 169–181,
1995.
[206] E. A. Groisman, “The pleiotropic two-component regulatory system PhoPPhoQ,” Journal of Bacteriology, vol. 183, no. 6, pp. 1835–1842, 2001.
[207] R. L. Smith and M. E. Maguire, “Microbial magnesium transport: unusual
transporters searching for identity,” Molecular Microbiology, vol. 28, no. 2, pp.
217–226, 1998.
[208] L. Guo, K. B. Lim, J. S. Gunn, B. Bainbridge, R. P. Darveau, M. Hackett, and
S. I. Miller, “Regulation of lipid A modiﬁcations by Salmonella typhimurium
virulence genes phoP-phoQ,” Science, vol. 276, no. 5310, pp. 250–253, 1997.
[209] R. E. Bishop, H. S. Gibbons, T. Guina, M. S. Trent, S. I. Miller, and C. R.
Raetz, “Transfer of palmitate from phospholipids to lipid A in outer membranes
of Gram-negative bacteria,” The EMBO Journal, vol. 19, no. 19, pp. 5071–5080,
2000.
[210] E. A. Groisman, J. Kayser, and F. C. Soncini, “Regulation of polymyxin resistance and adaptation to low-Mg2+ environments.” Journal of Bacteriology, vol.
179, no. 22, pp. 7040–7045, 1997.
[211] E. A. Groisman, C. Parra-Lopez, M. Salcedo, C. J. Lipps, and F. Heﬀron, “Resistance to host antimicrobial peptides is necessary for Salmonella virulence,”
Proceedings of the National Academy of Sciences, vol. 89, no. 24, pp. 11 939–
11 943, 1992.
[212] J. S. Gunn and S. I. Miller, “PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium
antimicrobial peptide resistance.” Journal of Bacteriology, vol. 178, no. 23, pp.
6857–6864, 1996.
[213] J. C. van Velkinburgh and J. S. Gunn, “PhoP-PhoQ-regulated loci are required
for enhanced bile resistance in Salmonella spp.” Infection and Immunity, vol. 67,
no. 4, pp. 1614–1622, 1999.

109
[214] F. Hilbert, F. G. del Portillo, and E. A. Groisman, “A periplasmic d-alanyld-alanine dipeptidase in the Gram-negative bacterium Salmonella enterica,”
Journal of Bacteriology, vol. 181, no. 7, pp. 2158–2165, 1999.
[215] A.-B. Blanc-Potard and E. A. Groisman, “The Salmonella selC locus contains a
pathogenicity island mediating intramacrophage survival,” The EMBO Journal,
vol. 16, no. 17, pp. 5376–5385, 1997.
[216] C. W. Ronson, B. T. Nixon, and F. M. Ausubel, “Conserved domains in bacterial regulatory proteins that respond to environmental stimuli,” Cell, vol. 49,
no. 5, pp. 579–581, 1987.
[217] J. Stock, A. Ninfa, and A. Stock, “Protein phosphorylation and regulation of
adaptive responses in bacteria.” Microbiological Reviews, vol. 53, no. 4, pp.
450–490, 1989.
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A. PLASMIDS USED IN THE STUDY
Table A.1.: List of plasmids used in the study

Plasmid Name

Description

pZP1137

pBAD vector with M45 tag

pSB1039

promoterless lacZ possessing suicide vector

pACYC-184SK low copy plasmid with p15A origin of replication
pEGFP-N2

Mammalian Expression vector as source of EGFP tag

pEX0233

pM1644

pEX0316

pKD4

pEX0317

pCP20

pEX0320

pKD46

pEX0342

pKT25zip pUT18C zip

pEX0345

pKT25

pEX0346

pUT18C

pEX0347

pEB1029

pEX0348

pEB1030

pZP545

plasmid with a SPI-2 induced promoter ProsseA

APA766

randomly barcoded pKMW7 library in WM3064

pZP2277

pM1644 with sipA replaced by the RfA cassette

pZP3398

STnc1450 in pZP1137

pZP3399

yshB with no ATG in pZP1137
continued on next page
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Table A.1.: continued

Plasmid Name

Description

pZP3400

yshB with frameshift in pZP1137

pZP3628

yshB in pZP1137 expressing YshB–M45–TEM

pZP3629

STnc590 in pZP1137

pZP3630

STnc600 in pZP1137

pZP3631

STnc180 in pZP1137

pZP3632

STnc190 in pZP1137

pZP3633

STnc200 in pZP1137

pZP3634

yshB with degenerate sequence in pZP1137

pZP3635

pVector with M45–TEM in pZP1137

pZP3636

pVector with EGFP from pEGFP-N2 in pZP1137

pZP3637

yshB expressed from its native promoter in pZP3636

pZP3638

yshB in pACYC–184SK expressing YshB–M45–TEM

pZP3639

yshB in pM1644 expressing YshB–M45–TEM

pZP3640

phoPQ-lacZ in pSB1039

pZP3641

ssrAB -lacZ in pSB1039

pZP3642

fadA in pZP1137

pZP3643

fadB -wt in pZP1137

pZP3644

fadB H450Q in pZP1137

pZP3645

fadB -wt in pZP545

pZP3646

fadB H450Q in pZP545

pZP3647

fadR in pZP1137

pZP3648

fadR in pZP545

pZP3649

yshB in pEB1029
continued on next page
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Table A.1.: continued

Plasmid Name

Description

pZP3650

yshB in pEB1030

pZP3651

fadB in pEB1029

pZP3652

fadB in pEB1030

pZP3653

fadR in pEB1029

pZP3654

fadR in pEB1030

pZP3655

phoP in pEB1029

pZP3656

phoP in pEB1030

pZP3657

phoQ in pEB1029

pZP3658

phoQ in pEB1030

pZP3659

phoP in pZP1137
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B. STRAINS USED IN THE STUDY
Table B.1.: List of strains used in the study

Strains Description
SB300

SL1344 WT

ZP18

ΔssaV

ZP128

ΔsipC

EX100

E. coli BTH101

ZP331

SB300 with pKD46

ZP413

ΔSTnc1450

ZP601

ΔSTnc180

ZP602

ΔSTnc200

ZP603

ΔSTnc290

ZP604

ΔSTnc1420

ZP605

ΔSTnc520

ZP606

ΔSTnc590

ZP607

ΔSTnc1640

ZP608

ΔSTnc740

ZP609

ΔSTnc800

ZP610

ΔSTnc840

ZP611

ΔSTnc850

ZP612

ΔSTnc880
continued on next page
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Table B.1.: continued

Strains Description
ZP613

ΔSTnc1030

ZP614

ΔSTnc1050

ZP615

ΔSTnc1100

ZP616

ΔSTnc1120

ZP617

ΔSTnc1130

ZP618

ΔSTnc1150

ZP619

ΔSTnc1170

ZP620

ΔSTnc1190

ZP621

ΔSTnc1200

ZP622

ΔSTnc1210

ZP623

ΔSTnc1220

ZP624

ΔSTnc1240

ZP625

ΔSTnc1270

ZP626

ΔSTnc1280

ZP627

ΔSTnc1300

ZP628

ΔSTnc1330

ZP629

ΔSTnc1350

ZP630

ΔSTnc1360

ZP631

ΔSTnc1380

ZP632

ΔSTnc1410

ZP633

ΔSTnc1430

ZP634

ΔSTnc1400

ZP635

ΔSTnc1460
continued on next page
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Table B.1.: continued

Strains Description
ZP636

ΔSTnc1470

ZP637

ΔSTnc1590

ZP638

ΔSTnc2090

ZP639

ΔSTnc2130

ZP640

ΔSTnc1440

ZP641

ΔSTnc190

ZP642

ΔSTnc1250

ZP643

ΔSTnc750

ZP644

ΔSTnc1370

ZP645

ΔSTnc1290

ZP646

ΔSTnc1340

ZP647

ΔSTnc1650

ZP648

ΔSTnc1160

ZP649

ΔSTnc2040

ZP650

ΔSTnc110

ZP651

ΔSTnc1390

ZP652

ΔyshB

ZP653

SB300 with pZP3398

ZP654

SB300 with pZP3399

ZP655

SB300 with pZP3400

ZP656

SB300 with pZP3628

ZP657

SB300 with pZP3629

ZP658

SB300 with pZP3630
continued on next page
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Table B.1.: continued

Strains Description
ZP659

SB300 with pZP3631

ZP660

SB300 with pZP3632

ZP661

SB300 with pZP3633

ZP662

SB300 with pZP3634

ZP663

SB300 with pZP3635

ZP664

SB300 with pZP3636

ZP665

SB300 with pZP3637

ZP666

SB300 with pZP3638

ZP667

SB300 with pZP3639

ZP668

SB300 with pZP3642

ZP669

SB300 with pZP3643

ZP670

SB300 with pZP3644

ZP671

SB300 with pZP3645

ZP672

SB300 with pZP3646

ZP673

SB300 with pZP3647

ZP674

SB300 with pZP3648

ZP675

ΔyshB with pZP3628

ZP676

ΔyshB with pZP3635

ZP677

ΔyshB with pZP3636

ZP678

ΔyshB with pZP3637

ZP679

SB300 with pM1644 and pZP3638

ZP680

SB300 with pZP3639

ZP681

phoPQ-lacZ in SB300 with pZP3628
continued on next page
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Table B.1.: continued

Strains Description
ZP682

phoPQ-lacZ in SB300 with pZP3635

ZP683

phoPQ-lacZ in ΔyshB with pZP3635

ZP684

ssrAB-lacZ in SB300 with pZP3628

ZP685

ssrAB-lacZ in SB300 with pZP3635

ZP686

PhoP-Flag in SB300 with pZP3628

ZP687

PhoP-Flag in SB300 with pZP3635

ZP688

PhoP-Flag in ΔyshB with pZP3635

ZP689

SsrB-Flag in SB300 with pZP3628

ZP690

SsrB-Flag in SB300 with pZP3635

ZP691

fadBA-lacZ in SB300 with pZP3628

ZP692

fadBA-lacZ in SB300 with pZP3635

ZP693

fadBA-lacZ in ΔyshB with pZP3635

ZP694

FadB-Flag in SB300 with pZP3628

ZP695

FadB-Flag in SB300 with pZP3635

ZP696

FadB-Flag in ΔyshB with pZP3635

ZP697

FadB-Flag in ΔfadR with pZP3628

ZP698

FadB-Flag in ΔfadR with pZP3635

ZP699

FadB-Flag in ΔfadR ΔyshB with pZP3628

ZP700

ΔfadL with pZP3628

ZP701

ΔfadL with pZP3635

ZP702

ΔfadL with pZP3643

ZP703

ΔfadL with pZP3644

ZP704

ΔfadB with pZP3628
continued on next page
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Table B.1.: continued

Strains Description
ZP705

ΔfadB with pZP3635

ZP706

ΔfadB with pZP3645

ZP707

ΔfadB with pZP3646

ZP708

ΔfadA

ZP709

ΔphoP with pZP3628

ZP710

ΔphoP with pZP3635

ZP711

ΔphoP ΔfadB with pZP3628

ZP712

ΔphoP ΔfadB with pZP3635

ZP713

ΔfadR

ZP714

ΔfadR with pZP3647

ZP715

ΔfadR with pZP3648

ZP716

BTH101 with pEX0342

ZP717

BTH101 with pZP3649 and pZP3652

ZP718

BTH101 with pZP3650 and pZP3651

ZP719

BTH101 with pZP3649 and pZP3654

ZP720

BTH101 with pZP3650 and pZP3653

ZP721

BTH101 with pZP3649 and pZP3656

ZP722

BTH101 with pZP3650 and pZP3655

ZP723

BTH101 with pZP3649 and pZP3658

ZP724

BTH101 with pZP3650 and pZP3657

ZP725

PhoP-Flag in SB300 with pZP3643

ZP726

FadB-Flag in SB300 with pZP3659

ZP727

FadB-Flag in ΔfadR with pZP3659
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C. QUANTITATIVE PROTEOMICS PROFILE OF
ALTERED PROTEINS UPON YSHB INDUCTION
Table C.1.: List of proteins whose levels were signiﬁcantly
altered upon YshB induction (FC: Fold change in YshB
induced strain)

Protein Name (Description)

FC

NapA (Periplasmic nitrate reductase)

0.54

NapC (Cytochrome c-type protein)

0.57

YbhL (Hypothetical membrane protein)

0.6

GlpC (Anaerobic glycerol-3-phosphate dehydrogenase subunit C)

0.63

FlgD (Flagellar hook formation protein)

0.65

CcmG2 (Cytochrome C-type biogenesis protein)

0.65

CcmE (Cytochrome C-type biogenesis protein)

0.66

DcuA (Anaerobic C4-dicarboxylate transporter)

0.66

FadA (3-ketoacyl-CoA thiolase )

1.62

RhlE (ATP-dependent RNA helicase)

1.65

CspJ (Cold shock-like protein)

1.66

CycA (D-serine/D-alanine/glycine transporter)

1.84

FadB (Fatty acid oxidation complex subunit alpha)

1.98

CspA (Cold shock protein)

3.14

RtcB (RNA-splicing ligase)

6.93

VITA
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